0001433660 12/31 2026 Q2 FALSE--12-31.00053258 6 1 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares jbt:segment xbrli:pure jbt:country iso4217:EUR utr:Rate jbt:instrument jbt:derivative jbt:day 0001433660 2026-01-01 2026-06-30 0001433660 2026-07-24 0001433660 2026-04-01 2026-06-30 0001433660 2025-04-01 2025-06-30 0001433660 2025-01-01 2025-06-30 0001433660 2026-06-30 0001433660 2025-12-31 0001433660 2024-12-31 0001433660 2025-06-30 0001433660 us-gaap:CommonStockMember 2026-03-31 0001433660 us-gaap:TreasuryStockCommonMember 2026-03-31 0001433660 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001433660 us-gaap:RetainedEarningsMember 2026-03-31 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001433660 2026-03-31 0001433660 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001433660 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001433660 us-gaap:CommonStockMember 2026-06-30 0001433660 us-gaap:TreasuryStockCommonMember 2026-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001433660 us-gaap:RetainedEarningsMember 2026-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001433660 us-gaap:CommonStockMember 2025-12-31 0001433660 us-gaap:TreasuryStockCommonMember 2025-12-31 0001433660 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001433660 us-gaap:RetainedEarningsMember 2025-12-31 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001433660 us-gaap:RetainedEarningsMember 2026-01-01 2026-06-30 0001433660 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-06-30 0001433660 us-gaap:CommonStockMember 2025-03-31 0001433660 us-gaap:TreasuryStockCommonMember 2025-03-31 0001433660 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001433660 us-gaap:RetainedEarningsMember 2025-03-31 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001433660 2025-03-31 0001433660 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001433660 us-gaap:CommonStockMember 2025-06-30 0001433660 us-gaap:TreasuryStockCommonMember 2025-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001433660 us-gaap:RetainedEarningsMember 2025-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001433660 us-gaap:CommonStockMember 2024-12-31 0001433660 us-gaap:TreasuryStockCommonMember 2024-12-31 0001433660 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001433660 us-gaap:RetainedEarningsMember 2024-12-31 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001433660 us-gaap:RetainedEarningsMember 2025-01-01 2025-06-30 0001433660 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001433660 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-06-30 0001433660 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-06-30 0001433660 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-06-30 0001433660 2026-05-14 0001433660 srt:ScenarioPreviouslyReportedMember 2025-01-01 2025-06-30 0001433660 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2025-01-01 2025-06-30 0001433660 jbt:MarelMember 2025-01-02 0001433660 jbt:MarelMember 2025-01-02 2025-01-02 0001433660 jbt:MarelMember 2025-02-04 0001433660 jbt:MarelMember 2025-02-04 2025-02-04 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-01-02 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2026-01-01 2026-06-30 0001433660 us-gaap:SecuredDebtMember 2025-01-02 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2026-01-01 2026-06-30 0001433660 jbt:MarelMember 2025-01-02 2025-06-30 0001433660 jbt:MarelMember 2025-01-01 2025-06-30 0001433660 jbt:MarelMember 2025-01-03 2025-09-30 0001433660 jbt:MarelMember 2026-06-30 0001433660 2025-01-02 0001433660 jbt:MarelMember us-gaap:CustomerRelationshipsMember 2025-01-02 0001433660 jbt:MarelMember us-gaap:CustomerRelationshipsMember 2025-01-03 2025-09-30 0001433660 jbt:MarelMember us-gaap:CustomerRelationshipsMember 2026-06-30 0001433660 jbt:MarelMember us-gaap:TechnologyBasedIntangibleAssetsMember 2025-01-02 0001433660 jbt:MarelMember us-gaap:TechnologyBasedIntangibleAssetsMember 2025-01-03 2025-09-30 0001433660 jbt:MarelMember us-gaap:TechnologyBasedIntangibleAssetsMember 2026-06-30 0001433660 jbt:MarelMember us-gaap:TrademarksMember 2025-01-02 0001433660 jbt:MarelMember us-gaap:TrademarksMember 2025-01-03 2025-09-30 0001433660 jbt:MarelMember us-gaap:TrademarksMember 2026-06-30 0001433660 jbt:MarelMember us-gaap:CustomerRelationshipsMember 2025-01-02 2025-01-02 0001433660 jbt:MarelMember us-gaap:TechnologyBasedIntangibleAssetsMember 2025-01-02 2025-01-02 0001433660 jbt:MarelMember us-gaap:TrademarksMember 2025-01-02 2025-01-02 0001433660 jbt:ProteinSolutionsMember 2025-12-31 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2025-12-31 0001433660 jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:ProteinSolutionsMember 2026-06-30 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2026-06-30 0001433660 us-gaap:CustomerRelationshipsMember 2026-06-30 0001433660 us-gaap:CustomerRelationshipsMember 2025-12-31 0001433660 jbt:PatentsAndAcquiredTechnologyMember 2026-06-30 0001433660 jbt:PatentsAndAcquiredTechnologyMember 2025-12-31 0001433660 us-gaap:TrademarksMember 2026-06-30 0001433660 us-gaap:TrademarksMember 2025-12-31 0001433660 us-gaap:OtherIntangibleAssetsMember 2026-06-30 0001433660 us-gaap:OtherIntangibleAssetsMember 2025-12-31 0001433660 us-gaap:CustomerRelationshipsMember 2026-01-01 2026-06-30 0001433660 jbt:PatentsAndAcquiredTechnologyMember 2026-01-01 2026-06-30 0001433660 us-gaap:PensionPlansDefinedBenefitMember 2026-01-01 2026-06-30 0001433660 2025-02-04 2025-02-04 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2026-06-30 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2025-12-31 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2026-06-30 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2025-12-31 0001433660 us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2026-01-01 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2025-12-31 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2026-01-01 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2025-12-31 0001433660 jbt:OtherDebtMember 2026-06-30 0001433660 jbt:OtherDebtMember 2025-12-31 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember 2026-06-30 0001433660 us-gaap:LineOfCreditMember 2026-06-30 0001433660 us-gaap:LineOfCreditMember 2025-12-31 0001433660 us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2025-09-09 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2026-04-01 2026-06-30 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2025-04-01 2025-06-30 0001433660 us-gaap:SecuredDebtMember us-gaap:SecuredDebtMember 2025-01-01 2025-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2026-04-01 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2025-04-01 2025-06-30 0001433660 us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2025-01-01 2025-06-30 0001433660 us-gaap:RevolvingCreditFacilityMember us-gaap:SecuredOvernightFinancingRateSofrMember 2025-01-02 2025-01-02 0001433660 us-gaap:LineOfCreditMember us-gaap:RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2025-01-02 2025-01-02 0001433660 us-gaap:SecuredDebtMember 2025-01-02 2025-01-02 0001433660 us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2021-05-28 2021-05-28 0001433660 jbt:A2026ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember 2021-06-30 0001433660 jbt:A2030ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember 2021-05-28 2021-05-28 0001433660 jbt:A2030ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember 2021-05-28 0001433660 jbt:A2030ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2026-06-30 0001433660 jbt:A2030ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember jbt:A2026ConvertibleSeniorNotesMember 2026-06-30 0001433660 jbt:A2030ConvertibleNoteWarrantMember us-gaap:ConvertibleDebtMember jbt:A2030ConvertibleSeniorNotesMember 2026-01-01 2026-06-30 0001433660 us-gaap:ConvertibleDebtMember 2025-09-09 2025-09-09 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-12-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-12-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2025-12-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-01-01 2026-03-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-01-01 2026-03-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2026-01-01 2026-03-31 0001433660 2026-01-01 2026-03-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-03-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-03-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2026-03-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-04-01 2026-06-30 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-04-01 2026-06-30 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2026-04-01 2026-06-30 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2026-06-30 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2026-06-30 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2026-06-30 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2024-12-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2024-12-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2024-12-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-01-01 2025-03-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-01-01 2025-03-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2025-01-01 2025-03-31 0001433660 2025-01-01 2025-03-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-03-31 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-03-31 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2025-03-31 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-04-01 2025-06-30 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-04-01 2025-06-30 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2025-04-01 2025-06-30 0001433660 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2025-06-30 0001433660 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2025-06-30 0001433660 us-gaap:AccumulatedTranslationAdjustmentMember 2025-06-30 0001433660 us-gaap:InterestExpenseNonoperating 2025-01-01 2025-06-30 0001433660 us-gaap:OtherNonoperatingIncome 2025-01-01 2025-06-30 0001433660 2026-07-01 srt:MinimumMember 2026-06-30 0001433660 2026-07-01 srt:MaximumMember 2026-06-30 0001433660 2027-01-01 srt:MinimumMember 2026-06-30 0001433660 2027-01-01 srt:MaximumMember 2026-06-30 0001433660 jbt:RecurringMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:RecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:RecurringMember 2024-04-01 2024-06-30 0001433660 jbt:RecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 jbt:NonRecurringMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:NonRecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:NonRecurringMember 2024-04-01 2024-06-30 0001433660 jbt:NonRecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 2024-04-01 2024-06-30 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 srt:NorthAmericaMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:NorthAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:NorthAmericaMember 2024-04-01 2024-06-30 0001433660 srt:NorthAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember 2024-04-01 2024-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 srt:AsiaPacificMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:AsiaPacificMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:AsiaPacificMember 2024-04-01 2024-06-30 0001433660 srt:AsiaPacificMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 srt:LatinAmericaMember jbt:ProteinSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:LatinAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-04-01 2026-06-30 0001433660 srt:LatinAmericaMember 2024-04-01 2024-06-30 0001433660 srt:LatinAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-04-01 2025-06-30 0001433660 jbt:RecurringMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:RecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:RecurringMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:RecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:NonRecurringMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:NonRecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:NonRecurringMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:NonRecurringMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:NorthAmericaMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:NorthAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:NorthAmericaMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:NorthAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 jbt:EuropeMiddleEastandAfricaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:AsiaPacificMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:AsiaPacificMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:AsiaPacificMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:AsiaPacificMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:LatinAmericaMember jbt:ProteinSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:LatinAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2026-01-01 2026-06-30 0001433660 srt:LatinAmericaMember jbt:ProteinSolutionsMember 2025-01-01 2025-06-30 0001433660 srt:LatinAmericaMember jbt:PreparedFoodAndBeverageSolutionsMember 2025-01-01 2025-06-30 0001433660 2025-01-01 2025-12-31 0001433660 2026-07-01 2026-06-30 0001433660 2027-01-01 2026-06-30 0001433660 2028-01-01 2026-06-30 0001433660 us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001433660 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001433660 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001433660 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001433660 us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001433660 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001433660 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001433660 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001433660 us-gaap:OtherAssetsCurrent us-gaap:FairValueMeasurementsRecurringMember 2026-06-30 0001433660 us-gaap:OtherAssetsCurrent us-gaap:FairValueMeasurementsRecurringMember 2025-12-31 0001433660 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2026-01-01 2026-06-30 0001433660 us-gaap:NondesignatedMember us-gaap:ForeignExchangeContractMember 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:Revenues 2026-04-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:Revenues 2025-04-01 2025-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:Revenues 2026-01-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:Revenues 2025-01-01 2025-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:CostOfRevenue 2026-04-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:CostOfRevenue 2025-04-01 2025-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:CostOfRevenue 2026-01-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:CostOfRevenue 2025-01-01 2025-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpense 2026-04-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-04-01 2025-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpense 2026-01-01 2026-06-30 0001433660 us-gaap:ForeignExchangeContractMember us-gaap:SellingGeneralAndAdministrativeExpense 2025-01-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncome us-gaap:ForeignExchangeContractMember 2026-04-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncome us-gaap:ForeignExchangeContractMember 2025-04-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncome us-gaap:ForeignExchangeContractMember 2026-01-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncome us-gaap:ForeignExchangeContractMember 2025-01-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:ForeignExchangeContractMember 2026-04-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:ForeignExchangeContractMember 2025-04-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:ForeignExchangeContractMember 2026-01-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:ForeignExchangeContractMember 2025-01-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:InterestRateSwapMember 2026-04-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:InterestRateSwapMember 2025-04-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:InterestRateSwapMember 2026-01-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseOperating us-gaap:InterestRateSwapMember 2025-01-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember 2026-04-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember 2025-04-01 2025-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember 2026-01-01 2026-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember 2025-01-01 2025-06-30 0001433660 jbt:CrossCurrencySwapsExpiringInJune2029And2031Member us-gaap:FairValueHedgingMember 2026-06-30 0001433660 jbt:CrossCurrencySwapsExpiringInJune2029Member us-gaap:FairValueHedgingMember 2026-03-31 0001433660 jbt:CrossCurrencySwapsExpiringInJune2030Member us-gaap:FairValueHedgingMember 2026-03-31 0001433660 jbt:CrossCurrencySwapsExpiringInJune2031Member us-gaap:FairValueHedgingMember 2026-03-31 0001433660 jbt:CrossCurrencySwapsExpiringInJune2029And2031Member us-gaap:FairValueHedgingMember 2025-12-31 0001433660 jbt:CrossCurrencySwapsExpiringInJanuary2032Member 2025-01-03 0001433660 jbt:CrossCurrencySwapsExpiringInJanuary2032Member us-gaap:FairValueHedgingMember 2025-01-03 0001433660 jbt:CrossCurrencySwapsExpiringInJanuary2032Member us-gaap:FairValueHedgingMember 2026-06-30 0001433660 jbt:CrossCurrencySwapsExpiringInJanuary2032Member us-gaap:FairValueHedgingMember 2025-12-31 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CashFlowHedgingMember 2025-01-01 2025-09-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember jbt:ForwardStartingInterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember jbt:ForwardStartingInterestRateSwapMember us-gaap:CashFlowHedgingMember 2023-06-30 0001433660 us-gaap:DesignatedAsHedgingInstrumentMember jbt:ForwardStartingInterestRateSwapMember us-gaap:CashFlowHedgingMember 2020-05-31 0001433660 us-gaap:PerformanceGuaranteeMember 2026-06-30 0001433660 us-gaap:FinancialGuaranteeMember 2026-06-30 0001433660 jbt:ProteinSolutionsMember 2025-04-01 2025-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember srt:MinimumMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember srt:MaximumMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:EmployeeSeveranceMember 2025-12-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:EmployeeSeveranceMember 2026-01-01 2026-03-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:EmployeeSeveranceMember 2026-04-01 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:EmployeeSeveranceMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember jbt:GainOnSaleOfBuildingMember 2025-12-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember jbt:GainOnSaleOfBuildingMember 2026-01-01 2026-03-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember jbt:GainOnSaleOfBuildingMember 2026-04-01 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember jbt:GainOnSaleOfBuildingMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:OtherRestructuringMember 2025-12-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:OtherRestructuringMember 2026-01-01 2026-03-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:OtherRestructuringMember 2026-04-01 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:OtherRestructuringMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2025-12-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2026-01-01 2026-03-31 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2026-04-01 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2025-04-01 2025-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember us-gaap:EmployeeSeveranceMember 2026-01-01 2026-06-30 0001433660 jbt:JBTMarel2025IntegrationRestructuringPlanMember 2026-01-01 2026-06-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM | 10-Q

☒ | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended June 30, 2026
or

☐ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| For the transition period from ______ to ______

Commission File Number 1-34036

JBT Marel Corporation
(Exact name of registrant as specified in its charter)
Delaware |  | 91-1650317
(State or other jurisdiction of |  | (I.R.S. Employer
incorporation or organization) |  | Identification No.)
333 West Wacker Drive, | Suite 3400 |  |  |  |
|  | Chicago, | Illinois |  |  | 60606
(Address of principal executive offices) |  | (Zip code)

(312) 861-5900
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: |  |
Title of each class |  | Trading symbol(s) |  | Name of each exchange on which registered
Common Stock, par value $0.01 per share |  | JBTM |  | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer | ☒ | Accelerated filer | ☐
Non-accelerated filer | ☐ | Smaller reporting company | ☐
|  | Emerging growth company | ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class |  | Outstanding at July 24, 2026
Common Stock, par value $0.01 per share |  | 51,876,817

1

PART I — FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
JBT MAREL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions, except per share data) | 2026 |  | 2025 |  | 2026 |  | 2025
Revenue | $ | 981 |  |  | $ | 935 |  |  | $ | 1,917 |  |  | $ | 1,789 |
Operating expenses: |  |  |  |  |  |  |
Cost of sales | 622 |  |  | 600 |  |  | 1,229 |  |  | 1,162 |
Selling, general and administrative expense | 313 |  |  | 287 |  |  | 574 |  |  | 612 |
Operating income | 46 |  |  | 48 |  |  | 114 |  |  | 15 |
Pension expense, other than service cost | — |  |  | — |  |  | — |  |  | 147 |
Loss on investment | — |  |  | 11 |  |  | — |  |  | 11 |
Interest expense, net | 13 |  |  | 29 |  |  | 23 |  |  | 70 |
Other income | (2) |  |  | (3) |  |  | (4) |  |  | (5) |
Income (loss) before income taxes | 35 |  |  | 11 |  |  | 95 |  |  | (208) |
Income tax provision (benefit) | 7 |  |  | 8 |  |  | 22 |  |  | (38) |
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Earnings (loss) per share: |  |  |  |  |  |  |
Basic | $ | 0.54 |  |  | $ | 0.07 |  |  | $ | 1.40 |  |  | $ | (3.27) |
Diluted | $ | 0.54 |  |  | $ | 0.07 |  |  | $ | 1.40 |  |  | $ | (3.27) |

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
2

JBT MAREL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) | 2026 |  | 2025 |  | 2026 |  | 2025
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Other comprehensive (loss) income, net of taxes |  |  |  |  |  |  |
Foreign currency translation adjustments | (20) |  |  | 269 |  |  | (37) |  |  | 423 |
Pension and other postretirement benefits adjustments | — |  |  | — |  |  | — |  |  | 112 |
Derivatives designated as hedges | 2 |  |  | (4) |  |  | — |  |  | (24) |
Other comprehensive (loss) income | (18) |  |  | 265 |  |  | (37) |  |  | 511 |
Comprehensive income | $ | 10 |  |  | $ | 268 |  |  | $ | 36 |  |  | $ | 341 |

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
3

JBT MAREL CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

(In millions, except for share data and number of shares) | June 30, 2026 |  | December 31, 2025
Assets: |  |  |
Current Assets: |  |  |
Cash and cash equivalents | $ | 93 |  |  | $ | 168 |
Restricted cash | 19 |  |  | 19 |
Trade receivables, net of allowances | 443 |  |  | 443 |
Contract assets | 144 |  |  | 119 |
Inventories | 700 |  |  | 644 |
Other current assets | 215 |  |  | 190 |
Total current assets | 1,614 |  |  | 1,583 |
Property, plant and equipment, net of accumulated depreciation of $423 and $392, respectively | 773 |  |  | 793 |
Goodwill | 3,385 |  |  | 3,428 |
Intangible assets, net | 1,972 |  |  | 2,122 |
Other assets | 262 |  |  | 265 |
Total Assets | $ | 8,006 |  |  | $ | 8,191 |
Liabilities and Stockholders’ Equity: |  |  |
Current Liabilities: |  |  |
Short-term debt | $ | 9 |  |  | $ | 412 |
Accounts payable, trade and other | 300 |  |  | 262 |
Advance and progress payments | 561 |  |  | 518 |
Accrued payroll | 157 |  |  | 170 |
Other current liabilities | 276 |  |  | 260 |
Total current liabilities | 1,303 |  |  | 1,622 |
Long-term debt | 1,670 |  |  | 1,470 |
Deferred tax liabilities | 356 |  |  | 383 |
Other liabilities | 205 |  |  | 252 |
Commitments and contingencies (Note 13) |  |  |
Stockholders’ Equity: |  |  |
Preferred stock, $0.01 par value; 20,000,000 shares authorized; no shares issued in 2026 or 2025 | — |  |  | — |
Common stock, $0.01 par value; 120,000,000 shares authorized; June 30, 2026: 52,075,770 issued, and 51,875,970 outstanding; December 31, 2025: 51,974,355 issued and outstanding | 1 |  |  | 1 |
Treasury stock, at cost June 30, 2026: 199,800 shares and December 31, 2025: 0 shares | (26) |  |  | — |
Additional paid-in capital | 2,726 |  |  | 2,717 |
Retained earnings | 1,527 |  |  | 1,465 |
Accumulated other comprehensive income | 244 |  |  | 281 |
Total stockholders’ equity | 4,472 |  |  | 4,464 |
Total Liabilities and Stockholders’ Equity | $ | 8,006 |  |  | $ | 8,191 |

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
4

JBT MAREL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

| Six Months Ended June 30,
(In millions) | 2026 |  | 2025
Cash flows from operating activities: |  |  |
Net income (loss) | $ | 73 |  |  | $ | (170) |
Adjustments to reconcile income (loss) to cash provided by operating activities: |  |  |
Depreciation and amortization | 134 |  |  | 143 |
Stock-based compensation | 19 |  |  | 9 |
Impairment of intangible assets | 33 |  |  | — |
Pension and other post-retirement benefits expense | — |  |  | 148 |
Other, net | 5 |  |  | 49 |
Changes in operating assets and liabilities: |  |  |
Trade receivables, net and contract assets | (29) |  |  | 31 |
Inventories | (60) |  |  | (65) |
Accounts payable, trade and other | 45 |  |  | 14 |
Advance and progress payments | 51 |  |  | 27 |
Other assets and liabilities, net | (50) |  |  | (49) |
Cash provided by operating activities | 221 |  |  | 137 |
Cash flows from investing activities: |  |  |
Acquisitions, net of cash acquired | — |  |  | (1,746) |
Capital expenditures | (51) |  |  | (39) |
Proceeds from disposal of assets | 9 |  |  | 5 |
Cash required by investing activities | (42) |  |  | (1,780) |
Cash flows from financing activities: |  |  |
Repayment of domestic credit facility | (314) |  |  | (1,368) |
Proceeds from domestic credit facility, net of debt issuance costs | 712 |  |  | 1,114 |
Proceeds from Term Loan B, net of debt issuance costs | — |  |  | 898 |
Repayment of Term Loan B | (202) |  |  | (2) |
Repayment of 2026 Notes | (403) |  |  | — |
Payment of debt issuance costs related to the Marel Transaction | — |  |  | (13) |
Acquisition of noncontrolling interest of Marel | — |  |  | (24) |
Settlement of taxes withheld on stock-based compensation awards | (10) |  |  | (8) |
Settlement of deal contingent hedge | — |  |  | (43) |
Dividends | (11) |  |  | (11) |
Purchases of treasury stock | (26) |  |  | — |
Cash (required) provided by financing activities | (254) |  |  | 543 |
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | 2 |
Net (decrease) increase in cash, cash equivalents and restricted cash | (75) |  |  | (1,098) |
Cash, cash equivalents, and restricted cash, beginning of period | 187 |  |  | 1,228 |
Cash, cash equivalents and restricted cash, end of period | $ | 112 |  |  | $ | 130 |
Reconciliation of cash, cash equivalents and restricted cash |  |  |
Cash and cash equivalents | $ | 93 |  |  | $ | 112 |
Restricted cash | 19 |  |  | 18 |
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows | $ | 112 |  |  | $ | 130 |

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
5

JBT MAREL CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
(Unaudited)

| Three Months Ended June 30, 2026
(In millions) | Common Stock |  | Common Stock Held in Treasury |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Equity
Balance at March 31, 2026 | $ | 1 |  |  | $ | — |  |  | $ | 2,715 |  |  | $ | 1,505 |  |  | $ | 262 |  |  | $ | 4,483 |
Net income | — |  |  | — |  |  | — |  |  | 28 |  |  | — |  |  | 28 |
Issuance of common stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Purchases of Treasury Stock | — |  |  | (26) |  |  | — |  |  | — |  |  | — |  |  | (26) |
Common stock cash dividends, $0.10 per share | — |  |  | — |  |  | — |  |  | (6) |  |  | — |  |  | (6) |
Foreign currency translation adjustments, net of income taxes of $3 | — |  |  | — |  |  | — |  |  | — |  |  | (20) |  |  | (20) |
Derivatives designated as hedges, net of income taxes of $(1) | — |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 2 |
Stock-based compensation expense | — |  |  | — |  |  | 12 |  |  | — |  |  | — |  |  | 12 |
Taxes withheld on issuance of stock-based awards | — |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (1) |
Other | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Balance at June 30, 2026 | $ | 1 |  |  | $ | (26) |  |  | $ | 2,726 |  |  | $ | 1,527 |  |  | $ | 244 |  |  | $ | 4,472 |

| Six Months Ended June 30, 2026
(In millions) | Common Stock |  | Common Stock Held in Treasury |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Equity
Balance at December 31, 2025 | $ | 1 |  |  | $ | — |  |  | $ | 2,717 |  |  | $ | 1,465 |  |  | $ | 281 |  |  | $ | 4,464 |
Net income | — |  |  | — |  |  | — |  |  | 73 |  |  | — |  |  | 73 |
Issuance of common stock | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Purchases of Treasury Stock | — |  |  | (26) |  |  | — |  |  | — |  |  | — |  |  | (26) |
Common stock cash dividends, $0.10 per share | — |  |  | — |  |  | — |  |  | (11) |  |  | — |  |  | (11) |
Foreign currency translation adjustments, net of income taxes of $(8) | — |  |  | — |  |  | — |  |  | — |  |  | (37) |  |  | (37) |
Derivatives designated as hedges, net of income taxes of $0 | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Stock-based compensation expense | — |  |  | — |  |  | 19 |  |  | — |  |  | — |  |  | 19 |
Taxes withheld on issuance of stock-based awards | — |  |  | — |  |  | (10) |  |  | — |  |  | — |  |  | (10) |
Other | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Balance at June 30, 2026 | $ | 1 |  |  | $ | (26) |  |  | $ | 2,726 |  |  | $ | 1,527 |  |  | $ | 244 |  |  | $ | 4,472 |

6

| Three Months Ended June 30, 2025
(In millions) | Common Stock |  | Common Stock Held in Treasury |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Equity
Balance at March 31, 2025 | $ | — |  |  | $ | — |  |  | $ | 2,727 |  |  | $ | 1,358 |  |  | $ | 22 |  |  | $ | 4,107 |
Net income | — |  |  | — |  |  | — |  |  | 3 |  |  | — |  |  | 3 |
Common stock cash dividends, $0.10 per share | — |  |  | — |  |  | — |  |  | (5) |  |  | — |  |  | (5) |
Foreign currency translation adjustments, net of income taxes of $3 | — |  |  | — |  |  | — |  |  | — |  |  | 269 |  |  | 269 |
Derivatives designated as hedges, net of income taxes of $1 | — |  |  | — |  |  | — |  |  | — |  |  | (4) |  |  | (4) |
Stock-based compensation expense | — |  |  | — |  |  | 5 |  |  | — |  |  | — |  |  | 5 |
Taxes withheld on issuance of stock-based awards | — |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | (1) |
Balance at June 30, 2025 | $ | — |  |  | $ | — |  |  | $ | 2,731 |  |  | $ | 1,356 |  |  | $ | 287 |  |  | $ | 4,374 |

| Six Months Ended June 30, 2025
(In millions) | Common Stock |  | Common Stock Held in Treasury |  | Additional Paid-In Capital |  | Retained Earnings |  | Accumulated Other Comprehensive Income (Loss) |  | Total Equity
Balance at December 31, 2024 | $ | — |  |  | $ | (2) |  |  | $ | 234 |  |  | $ | 1,536 |  |  | $ | (224) |  |  | $ | 1,544 |
Net loss | — |  |  | — |  |  | — |  |  | (170) |  |  | — |  |  | (170) |
Issuance of common stock | — |  |  | — |  |  | 2,498 |  |  | — |  |  | — |  |  | 2,498 |
Issuance of treasury stock | — |  |  | 2 |  |  | (2) |  |  | — |  |  | — |  |  | — |
Common stock cash dividends, $0.20 per share | — |  |  | — |  |  | — |  |  | (10) |  |  | — |  |  | (10) |
Foreign currency translation adjustments, net of income taxes of $3 | — |  |  | — |  |  | — |  |  | — |  |  | 423 |  |  | 423 |
Derivatives designated as hedges, net of income taxes of $8 | — |  |  | — |  |  | — |  |  | — |  |  | (24) |  |  | (24) |
Pension and other postretirement liability adjustments, net of income taxes of $(38) | — |  |  | — |  |  | — |  |  | — |  |  | 112 |  |  | 112 |
Stock-based compensation expense | — |  |  | — |  |  | 9 |  |  | — |  |  | — |  |  | 9 |
Taxes withheld on issuance of stock-based awards | — |  |  | — |  |  | (8) |  |  | — |  |  | — |  |  | (8) |
Balance at June 30, 2025 | $ | — |  |  | $ | — |  |  | $ | 2,731 |  |  | $ | 1,356 |  |  | $ | 287 |  |  | $ | 4,374 |

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
7

JBT MAREL CORPORATION
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1. DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Description of Business
JBT Marel Corporation and its majority-owned consolidated subsidiaries (the “Company,” “JBT Marel,” “our,” “us,” or “we”) provide global technology solutions to high-value segments of the food and beverage industry. The Company designs, produces and services sophisticated products and systems for multi-national and regional customers. The Company has manufacturing operations worldwide that are strategically located to facilitate delivery of its products and services to its customers.
Basis of Presentation
In accordance with Securities and Exchange Commission (“SEC”) rules for interim periods, the accompanying unaudited condensed consolidated financial statements (the “interim financial statements”) do not include all of the information and notes for complete financial statements as required by accounting principles generally accepted in the United States of America (“U.S. GAAP”). As such, the accompanying interim financial statements should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2025, which provides a more complete description of the Company’s accounting policies, financial position, operating results, business, properties, and other matters. The year-end Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all annual disclosures required by U.S. GAAP. Certain prior‑period amounts for the three and six months ended June 30, 2025 have been reclassified to conform to the presentation adopted for the three and six months ended June 30, 2026. These reclassifications had no impact on previously reported results of operations or financial position.
In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary for a fair statement of the Company's financial condition and operating results as of and for the periods presented. Revenue, expenses, assets and liabilities can vary during each quarter of the year. Therefore, the interim results and trends in the interim financial statements may not be representative of those for the full year or any future period.
Share Repurchase Program
On May 14, 2026, the Company's Board of Directors authorized a share repurchase program of up to $200 million of the Company's common stock through May 31, 2029. Additional information regarding the program is included in Part II, Item 2, "Unregistered Sales of Equity Securities and Use of Proceeds."
Business Segments
In the fourth quarter of 2025, we realigned our reportable segments to better reflect the integration of our new operating model. We now operate through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions.
The Protein Solutions segment includes businesses that provide solutions for initial stage processing and harvesting of animal proteins, primarily focusing on poultry, pork, fish, and beef. Examples of core technologies include primary processing systems, cut-up, bone detection and removal, portioning, and robotic batching.
The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready to eat or drink products. This segment also includes solutions that are often end-market agnostic, spanning protein, beverages, fruit & vegetables, pet food, ready meals, pharmaceuticals and neutraceuticals, and warehouse automation.
For further segment information, see below Note 14. Business Segment Information and Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations.
8

Strategic Acquisition of Marel hf.
On January 2, 2025, we completed the acquisition of Marel hf. (“Marel”), subsequently renamed JBT Marel ehf. (such acquisition, the “Marel Transaction”). The purpose of the Marel Transaction was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with long histories, complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide. For further information on the Marel Transaction, see below Note 2. Acquisitions.
In conjunction with the Marel Transaction, JBT changed its corporate name and stock ticker symbol to “JBT Marel Corporation” and “JBTM,” respectively, on January 2, 2025. Shares of JBTM remain listed on the New York Stock Exchange (NYSE) with a secondary listing on Nasdaq Iceland. Shares of JBTM commenced trading on both NYSE and Nasdaq Iceland on January 3, 2025.
Revision of Previously Issued Financial Statements
During 2025, the Company identified and corrected certain errors relating to the presentation of its Statements of Cash Flows specific to financing activities. The Company improperly reported revolving credit facility cash activity on a net basis, resulting in an understatement of gross repayments and borrowings for the revolving credit facility for the period ending June 30, 2025 as detailed below. Additionally, the Company improperly reported the current portion of the proceeds from Term Loan B as proceeds from the revolving credit facility, understating the proceeds from Term Loan B, net of debt issuance costs, for the period ending June 30, 2025, by the amounts noted below.

(In millions) | Six months ended June 30, 2025
Consolidated Statement of Cash Flows | As Reported |  | Adjustment |  | As Revised
Repayment of domestic credit facility | $ | (853) |  |  | (515) |  |  | $ | (1,368) |
Proceeds from domestic credit facility, net of debt issuance costs | $ | — |  |  | 1,114 |  |  | 1,114 |
Net proceeds from domestic credit facility, net of debt issuance costs | $ | 606 |  |  | (606) |  |  | $ | — |
Proceeds from Term Loan B, net of debt issuance costs | $ | 890 |  |  | 8 |  |  | $ | 898 |
Cash provided (required) by continuing financing activities | $ | 543 |  |  | — |  |  | $ | 543 |

Use of Estimates
Preparation of financial statements that follow U.S. GAAP requires management to make estimates and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Recently Adopted Accounting Standards
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326) (“ASU 2025-05”), which provides a practical expedient to measure credit losses on current accounts receivable and current contract assets. The practical expedient allows companies to assume that current conditions as of the balance sheet date do not change for the remaining life of the asset when measuring credit losses. The Company adopted ASU 2025-05 during the quarter ended March 31, 2026. The impact of the adoption was not material to the condensed consolidated financial statements.
Recently Issued Accounting Standards Not Yet Adopted
In November 2024, the FASB issued ASU 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024-03”), that requires disclosures of disaggregated information about certain income statement expense line items on an annual and interim basis. This standard will be effective for fiscal years beginning after December 15, 2026, with early adoption permitted, and will be applied prospectively, with the option to apply retrospectively. The Company is evaluating the impact of adopting this standard and currently expects ASU 2024-03 to impact its disclosures only.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) (“ASU 2025-06”). The amendment modernizes the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introduces a more judgment-based approach. ASU 2025-06 will
9

be effective for the fiscal year beginning January 1, 2028, and for interim periods beginning in that fiscal year, with early adoption permitted as of the beginning of a fiscal year. The standard may be applied prospectively, retrospectively, or through a modified prospective transition method. The Company is in the process of evaluating the impact of adopting this standard.
10

NOTE 2. ACQUISITIONS
On January 2, 2025, the Company acquired 97.5% of the equity interests of Marel hf. (“Marel”), a public limited liability company incorporated under the laws of Iceland, for $4,182 million, which is net of cash acquired of $90 million (the “Marel Transaction”). On February 4, 2025, the Company acquired the remaining 2.5% of Marel’s equity interests that were not acquired through the Marel Transaction, for approximately $89 million. The total purchase consideration of the acquisition of the non-controlling interest of Marel was comprised of approximately $64 million in equity consideration and $24 million in cash consideration. This transaction was accounted for as an equity transaction and was reflected within financing activities within the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025.
Marel is a global provider of advanced processing equipment, systems, software and services, primarily for the poultry, meat, and fish industries, as well as a provider of processing solutions for pet food, plant-based proteins and aqua feed, with a presence in over 30 countries. The purpose of the acquisition of Marel was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide.
As part of the Marel Transaction, the Company settled Marel's outstanding debt of $868 million. In addition, the Company amended its existing credit facility in conjunction with the acquisition. The Second Amended and Restated Credit Agreement provides for a $1.8 billion revolving credit facility, which matures on January 2, 2030, and a $900 million Senior Secured Term Loan B, which matures on January 2, 2032. The proceeds from these facilities were used to fund the cash consideration for the acquisition and to settle the outstanding debt of Marel at the acquisition date.
The consideration transferred to Marel shareholders on the acquisition date consisted of the following:

(In millions, except per share data and exchange rates) |
JBT shares issued to Marel shareholders | 19.5 |
JBT share price on January 2, 2025 | $ | 124.94 |
Value of JBT shares issued to Marel shareholders | $ | 2,436 |
Cash consideration to Marel shareholders (in €) | € | 927 |
EUR to USD Exchange Rate | 1.0353 €/$
Cash consideration to Marel shareholders (in $) | $ | 959 |
Settlement of Marel debt | $ | 868 |
Settlement of Marel interest rate swaps | $ | 3 |
Fair value of Marel stock options attributable to pre-combination vesting | $ | 6 |
Purchase consideration | $ | 4,272 |

This acquisition has been accounted for as a business combination. Tangible and identifiable intangible assets acquired and liabilities assumed were recorded at their respective estimated fair values. The excess consideration over the estimated fair value of the net assets received has been recorded as goodwill. The factors that contributed to the recognition of goodwill primarily relate to acquisition-driven anticipated cost savings and revenue enhancement synergies coupled with the assembled workforce acquired. Assembled workforce is not recognized separate and apart from goodwill as it is neither separable nor contractual in nature. Goodwill created as a result of the Marel acquisition is not deductible for tax purposes.
The acquisition of Marel provided revenue of $926 million and operating income of $5 million for the period from the acquisition date through June 30, 2025.
Acquisition-related transaction costs totaling $58 million were recorded as Selling, general and administrative expense in the Condensed Consolidated Statements of Income during the six months ended June 30, 2025.
The allocation of the purchase price presented below is based on the fair values of the assets acquired and liabilities assumed using valuation techniques including the income, market, and cost approaches. In the fourth quarter of 2025, the Company completed its valuation of the assets acquired and liabilities assumed and aligned certain accounting policies, including the accounting for research and development expenses. The purchase accounting for the Marel acquisition was final as of December 31, 2025.
11

The following table summarizes the fair values recorded for the assets acquired and liabilities assumed for Marel:

(In millions) | Preliminary Purchase Price Allocation |  | Measurement Period Adjustments(1) |  | Final Purchase Price Allocation
Financial assets | $ | 402 |  |  | $ | — |  |  | $ | 402 |
Inventories | 344 |  |  | (2) |  |  | 342 |
Property, plant and equipment | 493 |  |  | 61 |  |  | 554 |
Right-of-use assets | 42 |  |  | (5) |  |  | 37 |
Customer relationship | 1,570 |  |  | (410) |  |  | 1,160 |
Acquired technology | 410 |  |  | (40) |  |  | 370 |
Trademarks | 260 |  |  | (30) |  |  | 230 |
Deferred taxes | (515) |  |  | 112 |  |  | (403) |
Financial liabilities | (630) |  |  | (26) |  |  | (656) |
Total identifiable net assets | $ | 2,376 |  |  | $ | (340) |  |  | $ | 2,036 |
Purchase consideration | $ | 4,272 |  |  | $ | — |  |  | $ | 4,272 |
Noncontrolling interest (2) | $ | 86 |  |  | $ | — |  |  | $ | 86 |
Goodwill | $ | 1,982 |  |  | $ | 340 |  |  | $ | 2,322 |

(1) In the measurement period, the Company recorded measurement period adjustments to the purchase price allocation as it obtained information and completed its valuation of certain assets and liabilities. The impact of these adjustments was reflected as a net increase in goodwill.
(2) The Company acquired 97.5% of the equity interests of Marel and recognized a non-controlling interest in Marel on the acquisition date. The non-controlling interest was recognized at fair value, which was estimated based upon the trading price of the Company’s common stock on the acquisition date and the types of consideration that non-controlling interest holders were eligible to receive. The Company subsequently acquired the remaining 2.5% of Marel’s equity interests, as described above.
The acquired intangible assets are amortized on a straight-line basis over their estimated useful lives. The intangible assets acquired have estimated useful lives of 16 years for customer relationships, 21 years for acquired technology, and 26 years for trademarks.
12

NOTE 3. GOODWILL AND INTANGIBLE ASSETS
The changes in the carrying amount of goodwill by business segment were as follows:

(In millions) | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Total
Balance as of December 31, 2025 | $ | 2,306 |  |  | $ | 1,122 |  |  | $ | 3,428 |
Currency translation | (30) |  |  | (13) |  |  | (43) |
Balance as of June 30, 2026 | $ | 2,276 |  |  | $ | 1,109 |  |  | $ | 3,385 |

Intangible assets consisted of the following:

| June 30, 2026 |  | December 31, 2025
(In millions) | Carrying Amount |  | Accumulated Amortization |  | Carrying Amount |  | Accumulated Amortization
Customer relationship | $ | 1,625 |  |  | $ | 322 |  |  | $ | 1,691 |  |  | $ | 285 |
Patents and acquired technology | 560 |  |  | 168 |  |  | 590 |  |  | 165 |
Trademarks | 305 |  |  | 39 |  |  | 313 |  |  | 34 |
Non-amortizing intangible assets | 11 |  |  | — |  |  | 11 |  |  | — |
Other | 11 |  |  | 11 |  |  | 11 |  |  | 10 |
Total intangible assets | $ | 2,512 |  |  | $ | 540 |  |  | $ | 2,616 |  |  | $ | 494 |

Intangible asset amortization expense was $39 million and $48 million for the three months ended June 30, 2026 and 2025, respectively, and $78 million and $87 million for the six months ended June 30, 2026 and 2025, respectively.
During the three months ended June 30, 2026, the Company recorded a $33 million impairment charge related to acquired intangible assets within the Protein Solutions segment, consisting of $27 million related to customer relationships and $6 million related to patents and acquired technology. The impairment charge was recorded within Selling, general and administrative expenses. The impairment resulted from updated business forecasts for the affected operation. The impairment fully impaired the related acquired intangible assets and is not expected to materially affect the Company's future operating results.
NOTE 4. INVENTORIES
Inventories consisted of the following:

(In millions) | June 30, 2026 |  | December 31, 2025
Raw materials | $ | 210 |  |  | $ | 218 |
Work in process | 115 |  |  | 82 |
Finished goods | 410 |  |  | 375 |
Gross inventories before valuation adjustments | 735 |  |  | 675 |
Valuation adjustments | (35) |  |  | (31) |
Net inventories | $ | 700 |  |  | $ | 644 |

NOTE 5. PENSION
Termination of U.S. qualified defined benefit pension plan
During 2024, the Company obtained approval from its Board of Directors to settle all outstanding obligations of the U.S. qualified defined benefit pension plan (the “Plan”), through a combination of voluntary lump sum payments and the purchase of an annuity contract. On February 4, 2025, the Company completed the termination of the Plan via the purchase of an annuity contract for $179 million, funded entirely by the Plan assets. No additional cash contribution was required to settle the Company's outstanding obligations and terminate the Plan. Upon the termination, the Company recognized a pre-tax settlement charge of $147 million in Pension expense, other than service cost to recognize the remaining pre-tax accumulated other comprehensive loss related to the Plan in the first quarter of 2025.
13

NOTE 6. DEBT
The components of the Company's borrowings were as follows:

(In millions) | Maturity Date |  | June 30, 2026 |  | December 31, 2025
Revolving credit facility (1) | January 2, 2030 |  | $ | 437 |  |  | $ | 38 |
Less: unamortized debt issuance costs |  |  | (1) |  |  | — |
Revolving credit facility, net |  |  | 436 |  |  | 38 |
Senior Secured Term Loan B (2) | January 2, 2032 |  | 691 |  |  | 893 |
Less: unamortized debt issuance costs |  |  | (11) |  |  | (13) |
Senior Secured Term Loan B, net |  |  | 680 |  |  | 880 |
2030 Convertible senior notes (3) | September 15, 2030 |  | 575 |  |  | 575 |
Less: unamortized debt issuance costs |  |  | (15) |  |  | (15) |
Convertible senior notes, net |  |  | 560 |  |  | 560 |
2026 Convertible senior notes | May 15, 2026 |  | — |  |  | 403 |
Less: unamortized debt issuance costs |  |  | — |  |  | (1) |
Convertible senior notes, net |  |  | — |  |  | 402 |
Other (4) |  |  | 3 |  |  | 2 |
Total debt, including current portion |  |  | 1,679 |  |  | 1,882 |
Less: current portion of debt |  |  | 9 |  |  | 412 |
Long-term debt, net |  |  | $ | 1,670 |  |  | $ | 1,470 |

(1) Weighted-average interest rate at June 30, 2026 was 5.19%.
(2) Effective interest rate for the Term Loan B (as defined below) for the quarter ended June 30, 2026 was 5.40%.
(3) Effective interest rate for the 2030 Notes (as defined below) for the quarter ended June 30, 2026 was 0.93%.
(4) Foreign line of credit and other borrowing arrangements.
The Company had access to short-term financing of $41 million and $46 million as of June 30, 2026 and December 31, 2025, respectively.
Components of interest expense recognized for the Senior Secured Term Loan B (the “Term Loan B”) and the 0.375% Convertible Senior Notes due 2030 (the “2030 Notes”) were as follows:

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) | 2026 |  | 2025 |  | 2026 |  | 2025
Contractual interest expense, Term Loan B | $ | 12 |  |  | $ | 15 |  |  | $ | 24 |  |  | $ | 29 |
Interest cost related to amortization of issuance costs, Term Loan B | — |  |  | — |  |  | 1 |  |  | 1 |
Total interest expense, Term Loan B | $ | 12 |  |  | $ | 15 |  |  | $ | 25 |  |  | $ | 30 |
Contractual interest expense, the 2030 Notes | $ | 1 |  |  | $ | 1 |  |  | $ | 2 |  |  | $ | 1 |
Interest cost related to amortization of issuance costs, the 2030 Notes | 1 |  |  | — |  |  | 2 |  |  | 1 |
Total interest expense, the 2030 Notes | $ | 2 |  |  | $ | 1 |  |  | $ | 4 |  |  | $ | 2 |

14

Five-year Revolving Credit Facility
On January 2, 2025, the Company executed the Second Amended and Restated Credit Agreement (the “Second A&R Credit Agreement”), which provides for a $1.8 billion revolving credit facility that matures on January 2, 2030.
The revolving loans bear interest, at the Company’s option, at (1) the applicable borrowing rate (i.e. SOFR or EURIBOR) (subject to a floor rate of zero), or (2) an alternate base rate (which is the greater of Wells Fargo’s Prime Rate, the Federal Funds Rate plus 0.5%, or SOFR (subject to a floor rate of zero) plus 1.0%), plus, in each case, a margin dependent on the leverage ratio.
The Company's credit facility includes restrictive covenants that, if not met, could lead to renegotiation of its credit facility, a requirement to repay its borrowings, and/or a significant increase in its cost of financing. Restrictive covenants include a minimum interest coverage ratio, a maximum leverage ratio, as well as certain events of default. As of June 30, 2026, the Company was in compliance with its restrictive covenants.
Senior Secured Term Loan B
On January 2, 2025, the Company entered into a $900 million Senior Secured Term Loan B under the Second A&R Credit Agreement (the “Term Loan B”), which matures on January 2, 2032. The Company is required to make quarterly principal repayments equal to 0.25% of the initial Term Loan B.
Borrowings under the Term Loan B bear interest at the greater of (1) SOFR (subject to a floor rate of zero) or (2) a floor of 0%, plus an applicable margin of 1.75%.
The Notes
On September 9, 2025, the Company closed a private offering of $575 million aggregate principal amount of the 2030 Notes to qualified institutional buyers. Interest on the 2030 Notes is payable semi-annually in arrears on March 15 and September 15 of each year at a rate of 0.375% per year. The 2030 Notes will mature on September 15, 2030, unless earlier converted, redeemed or repurchased. The initial conversion rate of the 2030 Notes is 5.3258 shares of the Company’s common stock per $1,000 principal amount of notes, which is equivalent to an initial conversion price of approximately $187.77 per share. This conversion rate is subject to adjustment upon the occurrence of certain specified events.
In the second quarter of 2026, the Company’s 0.25% Convertible Senior Notes due 2026 (the “2026 Notes”), which were issued in the second quarter of 2021, matured. The Company satisfied the outstanding principal amount of $403 million through cash repayment at maturity in the second quarter of 2026.
Hedge Transactions
In connection with the issuance of the 2030 Notes, the Company entered into certain hedge transactions (the “Hedge Transactions”). The Hedge Transactions are expected generally to reduce the potential dilutive effect of the conversion of the 2030 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of the converted 2030 Notes, subject to customary adjustments.
The Company paid an aggregate amount of approximately $106 million for the related Hedge Transactions for the 2030 Notes. The Hedge Transactions cover, subject to anti-dilution adjustments, approximately 3.1 million shares of the Company’s common stock with respect to the 2030 Notes. This is the same number of shares initially underlying the 2030 Notes at the strike price of $187.77, subject to customary adjustments. The Hedge Transactions will expire upon the maturity of the 2030 Notes unless earlier exercised or terminated.
The Hedge Transactions meet the criteria in ASC 815-40 to be classified within Stockholders’ Equity, and therefore are not revalued after issuance.
The Company has made tax elections to integrate the 2030 Notes and the related Hedge Transactions, which results in the Hedge Transactions being deductible as original issue discount interest for tax purposes over the term of the 2030 Notes, with the associated deferred tax assets recorded as adjustments to Additional paid-in capital.
15

Warrant Transactions
In connection with the Hedge Transactions, the Company also entered into certain warrant transactions (the “Warrant Transactions”). The Warrant Transactions relate to warrants to acquire, subject to anti-dilution adjustments, approximately 3.1 million shares of the Company’s common stock with respect to the 2030 Notes, at initial strike prices of approximately $283.42 per share. The Company received aggregate proceeds of $51 million from the related Warrant Transactions for the 2030 Notes, with such proceeds partially offsetting the costs of entering into the related Hedge Transactions. The 2030 warrants expire in September 2030. The Company has outstanding warrants related to its 2026 Notes, which were repaid in full during the second quarter of 2026. The warrants expire in August 2026 and are not expected to have a material impact on the Company's financial position, results of operations, or cash flows.
If the market value per share of the common stock exceeds the strike price of the warrants, the warrants will have a dilutive effect on our earnings per share, unless the Company elects, subject to certain conditions, to settle the warrants in cash. The warrants meet the criteria in ASC 815-40 to be classified within Stockholders’ Equity, and therefore the warrants are not revalued after issuance.
NOTE 7. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
Accumulated other comprehensive income or loss (“AOCI”) represents the cumulative balance of other comprehensive income, net of tax, as of the balance sheet date. For the Company, AOCI is composed of adjustments related to pension and other postretirement benefit plans, derivatives designated as hedges, and foreign currency translation adjustments. Changes in the AOCI balances for the three and six months ended June 30, 2026 and 2025 by component are shown in the following tables:

(In millions) | Pension and Other Postretirement Benefits (1) |  | Derivatives Designated as Hedges (1) |  | Foreign Currency Translation and Other (1) |  | Total (1)
Beginning balance, December 31, 2025 | $ | (7) |  |  | $ | (18) |  |  | $ | 306 |  |  | $ | 281 |
Other comprehensive income before reclassification | — |  |  | (1) |  |  | (13) |  |  | (14) |
Amounts reclassified from accumulated other comprehensive income | — |  |  | (1) |  |  | (4) |  |  | (5) |
Balance, March 31, 2026 | (7) |  |  | (20) |  |  | 289 |  |  | 262 |
Other comprehensive income (loss) before reclassification | — |  |  | 4 |  |  | (15) |  |  | (11) |
Amounts reclassified from accumulated other comprehensive income | — |  |  | (2) |  |  | (5) |  |  | (7) |
Ending balance, June 30, 2026 | $ | (7) |  |  | $ | (18) |  |  | $ | 269 |  |  | $ | 244 |

(1) All amounts are net of income taxes.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the three and six months ended June 30, 2026 were immaterial. Reclassification adjustments for derivatives designated as hedges were $2 million and $4 million of benefit for the three- and six-month periods, respectively. Reclassification adjustments for foreign currency translation related to net investment hedges were $4 million of benefit for both the three and six months ended June 30, 2026. All amounts are presented net of tax.
16

(In millions) | Pension and Other Postretirement Benefits (1) |  | Derivatives Designated as Hedges (1) |  | Foreign Currency Translation |  | Total (1)
Beginning balance, December 31, 2024 | $ | (113) |  |  | $ | 2 |  |  | $ | (113) |  |  | $ | (224) |
Other comprehensive income (loss) before reclassification | 2 |  |  | (17) |  |  | 154 |  |  | 139 |
Amounts reclassified from accumulated other comprehensive income | 110 |  |  | (3) |  |  | — |  |  | 107 |
Balance, March 31, 2025 | (1) |  |  | (18) |  |  | 41 |  |  | 22 |
Other comprehensive income (loss) before reclassification | — |  |  | (1) |  |  | 269 |  |  | 268 |
Amounts reclassified from accumulated other comprehensive income | — |  |  | (3) |  |  | — |  |  | (3) |
Ending balance, June 30, 2025 | $ | (1) |  |  | $ | (22) |  |  | $ | 310 |  |  | $ | 287 |

(1) All amounts are net of income taxes.
Reclassification adjustments from AOCI into earnings for pension and other postretirement benefit plans for the six months ended June 30, 2025 were $147 million of charges to pension expense, other than service cost, net of $37 million in benefit for income taxes. Reclassification adjustments for derivatives designated as hedges for the same period were $5 million of benefit, including $2 million recognized in interest expense and $3 million recognized in other income, net of related income tax effects. There were no reclassification adjustments related to foreign currency translation for the six months ended June 30, 2025.
NOTE 8. REVENUE RECOGNITION
Transaction price allocated to remaining performance obligations
The Company has estimated that $1.5 billion in revenue is expected to be recognized in future periods related to remaining performance obligations from the Company's contracts with customers outstanding as of June 30, 2026. The Company expects to complete these obligations and recognize revenue in the range of 60% to 70% during 2026, 30% to 40% during 2027, and the remainder after 2027.
Disaggregation of Revenue
In the following table, revenue is disaggregated by type of good or service and primary geographical market. The table also includes a reconciliation of the disaggregated revenue to total revenue.

| Three Months Ended June 30, 2026 |  | Three Months Ended June 30, 2025 (3)
(In millions) | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Protein Solutions |  | Prepared Food and Beverage Solutions
Type of Good or Service |  |  |  |  |  |  |
Recurring (1) | $ | 239 |  |  | $ | 258 |  |  | $ | 228 |  |  | $ | 257 |
Non-recurring (1) | 228 |  |  | 256 |  |  | 193 |  |  | 257 |
Total | 467 |  |  | 514 |  |  | 421 |  |  | 514 |
Geographical Region (2) |  |  |  |  |  |  |
U.S. and Canada | 146 |  |  | 233 |  |  | 129 |  |  | 253 |
Europe, Middle East and Africa | 239 |  |  | 180 |  |  | 197 |  |  | 165 |
Asia Pacific | 41 |  |  | 40 |  |  | 48 |  |  | 53 |
Latin America | 41 |  |  | 61 |  |  | 47 |  |  | 43 |
Total | 467 |  |  | 514 |  |  | 421 |  |  | 514 |

17

| Six Months Ended June 30, 2026 |  | Six Months Ended June 30, 2025 (3)
(In millions) | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Protein Solutions |  | Prepared Food and Beverage Solutions
Type of Good or Service |  |  |  |  |  |  |
Recurring (1) | $ | 474 |  |  | $ | 508 |  |  | $ | 437 |  |  | $ | 497 |
Non-recurring (1) | 453 |  |  | 482 |  |  | 362 |  |  | 493 |
Total | 927 |  |  | 990 |  |  | 799 |  |  | 990 |
Geographical Region (2) |  |  |  |  |  |  |
U.S. and Canada | 279 |  |  | 456 |  |  | 258 |  |  | 470 |
Europe, Middle East and Africa | 496 |  |  | 342 |  |  | 370 |  |  | 339 |
Asia Pacific | 70 |  |  | 79 |  |  | 85 |  |  | 93 |
Latin America | 82 |  |  | 113 |  |  | 86 |  |  | 88 |
Total | 927 |  |  | 990 |  |  | 799 |  |  | 990 |

(1) Recurring revenue includes revenue from aftermarket parts and services, re-build services on customer owned equipment, operating leases of equipment, and subscription-based software applications. Non-recurring revenue includes new equipment and installation and the sale of software licenses.
(2) Geographical region represents the region in which the end customer resides.
(3) Segment revenues for the three and six months ended June 30, 2025 were recast to reflect the Company’s realignment of its reportable segments, effective in the fourth quarter of 2025.
Contract balances
The timing of revenue recognition, billings and cash collections results in trade receivables, contract assets, and advance and progress payments (contract liabilities). Contract assets exist when revenue recognition occurs prior to billings. Contract assets are transferred to trade receivables when the right to payment becomes unconditional (i.e., when receipt of the amount is dependent only on the passage of time). Conversely, the Company often receives payments from its customers before revenue is recognized, resulting in contract liabilities. These assets and liabilities are reported on the Condensed Consolidated Balance Sheets as Contract assets and within Advance and progress payments, respectively, on a contract-by-contract net basis at the end of each reporting period.
Contract asset and liability balances for the period were as follows:

| Balances as of
(In millions) | June 30, 2026 |  | December 31, 2025
Contract Assets | $ | 144 |  |  | $ | 119 |
Contract Liabilities | 545 |  |  | 499 |
| June 30, 2025 |  | December 31, 2024
Contract Assets | 129 |  |  | 95 |
Contract Liabilities | 508 |  |  | 178 |

The revenue recognized during the six months ended June 30, 2026 and 2025 that was included in contract liabilities at the beginning of the period amounted to $245 million and $145 million, respectively. The Company assumed contract liabilities from acquisitions in the amount of $263 million in 2025. The remainder of the change from December 31, 2025 and December 31, 2024 is driven by the timing of advance and milestone payments received from customers, customer returns and fulfillment of performance obligations. There were no significant changes in the contract balances other than those described above.
18

NOTE 9. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share from net income (loss) for the respective periods and basic and diluted shares outstanding:

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions, except per share data) | 2026 |  | 2025 |  | 2026 |  | 2025
Basic earnings (loss) per share: |  |  |  |  |  |  |
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Weighted average number of shares outstanding | 52.1 |  |  | 52.1 |  |  | 52.1 |  |  | 51.9 |
Basic earnings per share from net income (loss) | $ | 0.54 |  |  | $ | 0.07 |  |  | $ | 1.40 |  |  | $ | (3.27) |
Diluted earnings (loss) per share: |  |  |  |  |  |  |
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Weighted average number of shares outstanding | 52.1 |  |  | 52.1 |  |  | 52.1 |  |  | 51.9 |
Effect of dilutive securities: |  |  |  |  |  |  |
Restricted stock (1) | 0.1 |  |  | 0.1 |  |  | 0.2 |  |  | — |
Total shares and dilutive securities | 52.2 |  |  | 52.2 |  |  | 52.3 |  |  | 51.9 |
Diluted earnings per share from net income (loss) | $ | 0.54 |  |  | $ | 0.07 |  |  | $ | 1.40 |  |  | $ | (3.27) |
Restricted stock shares with anti-dilutive effect excluded from the computation of diluted earnings per share(1) | — |  |  | — |  |  | — |  |  | 0.1 |

(1) As a result of the net loss recognized for the six months ended June 30, 2025, the effect of unvested equity awards was antidilutive and has been excluded from the diluted earnings per share calculation.
NOTE 10. FAIR VALUE OF FINANCIAL INSTRUMENTS
The fair value framework requires the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
•Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities that the Company can assess at the measurement date.
•Level 2: Observable inputs other than those included in Level 1 that are observable for the asset or liability, either directly or indirectly. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
•Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
Financial assets and financial liabilities measured at fair value on a recurring basis are as follows:

| As of June 30, 2026 |  | As of December 31, 2025
(In millions) | Total |  | Level 1 |  | Level 2 |  | Level 3 |  | Total |  | Level 1 |  | Level 2 |  | Level 3
Assets: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Investments | $ | 37 |  |  | $ | 37 |  |  | $ | — |  |  | $ | — |  |  | $ | 36 |  |  | $ | 36 |  |  | $ | — |  |  | $ | — |
Derivatives | 10 |  |  | — |  |  | 10 |  |  | — |  |  | 4 |  |  | — |  |  | 4 |  |  | — |
Total assets | $ | 47 |  |  | $ | 37 |  |  | $ | 10 |  |  | $ | — |  |  | $ | 40 |  |  | $ | 36 |  |  | $ | 4 |  |  | $ | — |
Liabilities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivatives | $ | 99 |  |  | $ | — |  |  | $ | 99 |  |  | $ | — |  |  | $ | 143 |  |  | $ | — |  |  | $ | 143 |  |  | $ | — |
Total liabilities | $ | 99 |  |  | $ | — |  |  | $ | 99 |  |  | $ | — |  |  | $ | 143 |  |  | $ | — |  |  | $ | 143 |  |  | $ | — |

Investments represent securities held in a trust for the non-qualified deferred compensation plan and the executive severance plan. Investments are classified as trading securities and are valued based on quoted prices in active markets for identical assets
19

that the Company has the ability to access. As of June 30, 2026 and December 31, 2025, $1 million and $2 million, respectively, of investments are recorded in Other current assets in the Condensed Consolidated Balance Sheets related to investments that are expected to be redeemed within the next twelve months. The remaining investments are reported separately in Restricted cash and Other assets in the Condensed Consolidated Balance Sheets.
The Company uses the income approach to measure the fair value of derivative instruments on a recurring basis. This approach calculates the present value of the future cash flow by measuring the change between the derivative contract rate and the published market indicative currency rate, multiplied by the contract notional values, and applying an appropriate discount rate as well as a factor of credit risk.
The Notes are not registered securities nor listed on any securities exchange but may be traded by qualified institutional buyers. As of June 30, 2026, the fair value of the 2030 Notes estimated using Level 2 inputs was $583 million.
The carrying amounts of cash and cash equivalents, trade receivables and payables, marketable securities, as well as financial instruments included in Other current assets and Other current liabilities, approximate fair values because of their short-term maturities.
The carrying values of the Company's revolving credit facility and Term Loan B recorded in Long-term debt on the Condensed Consolidated Balance Sheets approximate their fair values due to the borrowings variable interest rates.
NOTE 11. DERIVATIVE FINANCIAL INSTRUMENTS AND RISK MANAGEMENT
Derivative financial instruments
All derivatives are recorded as assets or liabilities in the Condensed Consolidated Balance Sheets at their respective fair values. For derivatives designated as cash flow and fair value hedges, the unrealized gain or loss related to the derivatives is recorded in Other comprehensive income (loss) until the hedged transaction affects earnings. The Company assesses at the inception of the hedge, whether the derivative in the hedging transaction will be highly effective in offsetting changes in cash flows or in fair value of the hedged item. Changes in the fair value of derivatives that do not meet the criteria for designation as a hedge are recognized in earnings.
Foreign Exchange: The Company manufactures and sells products in a number of countries throughout the world and, as a result, the Company is exposed to movements in foreign currency exchange rates. The Company's major foreign currency exposures involve the markets in Western Europe, South America and Asia. Some sales and purchase contracts contain embedded derivatives due to the nature of doing business in certain jurisdictions, which the Company takes into consideration as part of its risk management policy. The purpose of foreign currency hedging activities is to manage the economic impact of exchange rate volatility associated with anticipated foreign currency purchases and sales made in the normal course of business. The Company primarily utilizes forward foreign exchange contracts with maturities of less than one year in managing this foreign exchange rate risk. The Company has not designated these forward foreign exchange contracts, which had a notional value at June 30, 2026 of $447 million, as hedges and therefore does not apply hedge accounting.
The fair values of our foreign currency derivative assets are recorded within Other current assets and Other assets, and the fair values of foreign currency derivative liabilities are recorded within Other current liabilities and Other liabilities. The following table presents the fair value of foreign currency derivatives and embedded derivatives included within the Condensed Consolidated Balance Sheets:

| As of June 30, 2026 |  | As of December 31, 2025
(In millions) | Derivative Assets |  | Derivative Liabilities |  | Derivative Assets |  | Derivative Liabilities
Total | $ | 4 |  |  | $ | 5 |  |  | $ | 4 |  |  | $ | 3 |

A master netting arrangement allows counterparties to net settle amounts owed to each other as a result of separate offsetting derivative transactions. The Company enters into master netting arrangements with its counterparties when possible to mitigate credit risk in derivative transactions by permitting it to net settle for transactions with the same counterparty. However, the Company does not net settle with such counterparties. As a result, derivatives are presented at their gross fair values in the Condensed Consolidated Balance Sheets.
20

As of June 30, 2026 and December 31, 2025, information related to these offsetting arrangements was as follows:

(In millions) | As of June 30, 2026
Offsetting of Assets | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Amount Subject to Master Netting Agreement |  | Net Amount
Derivatives | $ | 10 |  |  | $ | — |  |  | $ | 10 |  |  | $ | (2) |  |  | $ | 8 |

(In millions) | As of June 30, 2026
Offsetting of Liabilities | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Amount Subject to Master Netting Agreement |  | Net Amount
Derivatives | $ | 99 |  |  | $ | — |  |  | $ | 99 |  |  | $ | (2) |  |  | $ | 97 |

(In millions) | As of December 31, 2025
Offsetting of Assets | Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Amount Subject to Master Netting Agreement |  | Net Amount
Derivatives | $ | 4 |  |  | $ | — |  |  | $ | 4 |  |  | $ | (2) |  |  | $ | 2 |

(In millions) | As of December 31, 2025
Offsetting of Liabilities | Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Consolidated Balance Sheets |  | Net Presented in the Consolidated Balance Sheets |  | Amount Subject to Master Netting Agreement |  | Net Amount
Derivatives | $ | 142 |  |  | $ | — |  |  | $ | 142 |  |  | $ | (2) |  |  | $ | 140 |

The following table presents the location and amount of the gain on foreign currency derivatives and on the remeasurement of assets and liabilities denominated in foreign currencies, as well as the net impact recognized in the Condensed Consolidated Statements of Income:

Derivatives Not Designated as Hedging Instruments |  | Location of Gain (Loss) Recognized in Income on Derivatives | Amount of Gain Recognized in Income
|  |  | Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) |  |  | 2026 |  | 2025 |  | 2026 |  | 2025
Foreign exchange contracts |  | Revenue | $ | 1 |  |  | $ | 2 |  |  | $ | (1) |  |  | $ | 6 |
Foreign exchange contracts |  | Cost of sales | (1) |  |  | (2) |  |  | 1 |  |  | (4) |
Foreign exchange contracts |  | Selling, general and administrative expense | (1) |  |  | 1 |  |  | (1) |  |  | 4 |
Total |  |  | (1) |  |  | 1 |  |  | (1) |  |  | 6 |
Remeasurement of assets and liabilities in foreign currencies |  |  | 2 |  |  | (4) |  |  | 3 |  |  | (6) |
Net gain (loss) |  |  | $ | 1 |  |  | $ | (3) |  |  | $ | 2 |  |  | $ | — |

21

The following table presents the location and amount of the gain (loss) on derivatives that have been designated as hedging instruments in the Condensed Consolidated Statements of Income:

Derivatives Designated as Hedging Instruments |  | Location of Gain (Loss) Recognized in Income on Derivatives | Amount of Gain (Loss) Recognized in Income
|  |  | Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) |  |  | 2026 |  | 2025 |  | 2026 |  | 2025
Foreign currency derivatives |  | Other income | $ | 2 |  |  | $ | 3 |  |  | $ | 4 |  |  | $ | 5 |
Foreign currency derivatives |  | Interest expense | — |  |  | — |  |  | 6 |  |  | — |
Interest rate swaps |  | Interest expense | — |  |  | — |  |  | — |  |  | 2 |
Total gain |  |  | $ | 2 |  |  | $ | 3 |  |  | $ | 10 |  |  | $ | 7 |

Net Investment: The Company uses cross currency swaps to hedge portions of its net investments denominated in Euro against the effect of adverse foreign exchange rate fluctuations on the translation of foreign currency balances to the U.S. dollar. The gains or losses on these derivative instruments are included in the foreign currency translation component of other comprehensive income until the net investment is sold, diluted, or liquidated. The Company elected to use the spot method to assess the effectiveness for these derivatives that are designated as net investment hedges for accounting purposes. Coupons received for the cross currency swaps are excluded from the net investment hedge effectiveness assessment and are recorded in Interest expense in the Condensed Consolidated Statements of Income. Cash flows related to coupons received on the swaps are included in operating activities in the Condensed Consolidated Statements of Cash Flows and the final exchange on the swaps will be reported in financing activities.
In the second and third quarters of 2025, the Company entered into a series of cross currency swap agreements that synthetically swap U.S. dollar denominated fixed rate debt to Euro denominated fixed rate debt with a combined notional amount of $2 billion. These cross currency swaps were designated as net investment hedges. Swaps with a combined notional amount of $986 million mature in June 2029, $578 million mature in June 2030, and $581 million mature in June 2031, respectively.
At June 30, 2026, the fair value of these derivatives designated as net investment hedges were recorded in the Condensed Consolidated Balance Sheets as Other liabilities of $7 million and as Accumulated other comprehensive loss, net of tax, of $5 million. At December 31, 2025, the fair value of these derivatives designated as net investment hedges were recorded in the Condensed Consolidated Balance Sheets as Other liabilities of $23 million and as Accumulated other comprehensive income, net of tax, of $17 million.
Fair Value: On January 3, 2025, the Company entered into five cross-currency swaps expiring in January 2032 related to the portion of the U.S. dollar denominated Term Loan B drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $691 million and synthetically swap interest rates from SOFR to EURIBOR and hedge the impact of variability in exchange rates on the U.S. dollar denominated debt and related interest payments, excluding the credit spread, by our euro-functional entity.
The Company has designated these swaps as fair value hedges and changes in the fair value of these swaps are recognized in earnings in the period realized. The gains and losses related to the change in the fair value of the hedged components of the swaps are included in other income and substantially offset the change in the fair value of the hedged portion of the underlying debt that is attributable to the change in euro to U.S. dollar exchange rates. Changes in fair value of the swaps related to excluded components of the derivative instruments are recognized in Accumulated other comprehensive income and recognized into earnings systematically over the life of the hedged instrument.
At June 30, 2026, the fair value of these derivatives designated as fair value hedges was recorded in the Condensed Consolidated Balance Sheets as Other liabilities of $93 million and as Accumulated other comprehensive income, net of tax, of $19 million. At December 31, 2025, the fair value of these derivatives designated as fair value hedges was recorded in the Condensed Consolidated Balance Sheets as Other liabilities of $117 million and as Accumulated other comprehensive income, net of tax, of $20 million.
Interest Rates: In March 2020, the Company executed four interest rate swaps with a combined notional amount of $200 million and in May 2020 the Company executed one interest rate swap with a notional amount of $50 million. These
22

interest rate swaps fixed the interest rate applicable to certain of the Company's variable-rate debt and swapped one-month SOFR rates for fixed rates. The Company designated these swaps as cash flow hedges and all changes in fair value of the swaps were recognized in Accumulated other comprehensive income. The interest rate swaps expired during the second quarter of 2025.
Refer to Note 10. Fair Value Of Financial Instruments for a description of how the values of the above financial instruments are determined.
Credit Risk
By their nature, financial instruments involve risk including credit risk for non-performance by counterparties. Financial instruments that potentially subject the Company to credit risk primarily consist of trade receivables and derivative contracts. The Company manages the credit risk on financial instruments by transacting only with financially secure counterparties, requiring credit approvals and establishing credit limits, and monitoring counterparties’ financial condition. The Company's maximum exposure to credit loss in the event of non-performance by the counterparty, for all receivables and derivative contracts as of June 30, 2026, is limited to the amount drawn and outstanding on the financial instrument. Refer to Note 1. Description of Business and Basis of Presentation in Item 8. Financial Statements and Supplementary Data of the Company's most recent Annual Report on Form 10-K, for a description of how allowance for credit loss is determined on financial assets measured at amortized cost, which includes Trade receivables, Contract assets, and non-current receivables.
NOTE 12. LEASES
The following table provides the required information regarding operating leases for which the Company is lessor.

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) | 2026 |  | 2025 |  | 2026 |  | 2025
Fixed payment revenue | $ | 19 |  |  | $ | 18 |  |  | $ | 37 |  |  | $ | 34 |
Variable payment revenue | 9 |  |  | 7 |  |  | 20 |  |  | 16 |
Operating lease revenue | $ | 28 |  |  | $ | 25 |  |  | $ | 57 |  |  | $ | 50 |

The Company’s sales‑type lease activity was not material for the three and six months ended June 30, 2026 and 2025.
NOTE 13. COMMITMENTS AND CONTINGENCIES
In the normal course of business, the Company is at times subject to pending and threatened legal actions, some for which the relief or damages sought may be substantial. Although the Company is not able to predict the outcome of such actions, after reviewing all pending and threatened actions with counsel and based on information currently available, management believes that the outcome of such actions, individually or in the aggregate, will not have a material adverse effect on the Company's results of operations or financial position. However, it is possible that the ultimate resolution of such matters, if unfavorable, may be material to its results of operations in a particular future period as the time and amount of any resolution of such actions and its relationship to the future results of operations are not currently known.
Liabilities are established for pending legal claims only when losses associated with the claims are judged to be probable, and the loss can be reasonably estimated. In many lawsuits and arbitrations, it is considered not probable that a liability has been incurred or not possible to estimate the ultimate or minimum amount of that liability until the case is close to resolution, in which case no liability would be recognized until that time.
Guarantees and Product Warranties
In the ordinary course of business with customers, vendors and others, the Company issues standby letters of credit, performance bonds, surety bonds and other guarantees. These financial instruments, which totaled $93 million at June 30, 2026, represent guarantees of future performance. The Company has also provided approximately $10 million of bank guarantees and letters of credit to secure a portion of its existing financial obligations. The majority of these financial instruments expire within one year and are expected to be replaced through the issuance of new or the extension of existing letters of credit and surety bonds.
23

In some instances, the Company guarantees its customers’ financing arrangements. The Company is responsible for payment of any unpaid amounts, but will receive indemnification from third parties for ninety percent of the contract values. In addition, the Company generally retains recourse to the equipment sold. As of June 30, 2026, the gross value of these arrangements was not material.
The Company provides warranties of various lengths and terms to certain customers based on standard terms and conditions and negotiated agreements. The Company provides for the estimated cost of warranties at the time revenue is recognized for products where reliable, historical experience of warranty claims and costs exist. The Company also provides a warranty liability when additional specific obligations are identified. The warranty obligation reflected in Other current liabilities in the Condensed Consolidated Balance Sheets is based on historical experience by product and considers failure rates and the related costs in correcting a product failure. Warranty cost and accrual information were as follows:

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) | 2026 |  | 2025 |  | 2026 |  | 2025
Balance at beginning of period | $ | 21 |  |  | $ | 22 |  |  | $ | 21 |  |  | $ | 12 |
Expense for new warranties | 4 |  |  | 3 |  |  | 7 |  |  | 6 |
Adjustments to existing accruals | — |  |  | — |  |  | (1) |  |  | — |
Claims paid | (7) |  |  | (2) |  |  | (9) |  |  | (4) |
Added through acquisition | — |  |  | — |  |  | — |  |  | 8 |
Translation | — |  |  | 1 |  |  | — |  |  | 2 |
Balance at end of period | $ | 18 |  |  | $ | 24 |  |  | $ | 18 |  |  | $ | 24 |

24

NOTE 14. BUSINESS SEGMENT INFORMATION
In the fourth quarter of 2025, the Company realigned its reportable segments to better reflect the continued integration of its operating model. Giving effect to the realignment, the Company operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Company defines its segments based on which internally reported financial information is regularly reviewed by the Chief Operating Decision Maker (CODM) to analyze financial performance, make decisions, and allocate resources.
•The Protein Solutions segment includes businesses that provide solutions for initial stage processing and harvesting of animal proteins, primarily focusing on poultry, pork, fish, and beef.
•The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready to eat or drink products. This segment also includes solutions that are often end-market agnostic, spanning protein, beverages, fruit & vegetables, pet food, ready meals, pharmaceuticals and neutraceuticals, and warehouse automation.
The Company's Chief Executive Officer is the CODM, who assesses the segments’ performance using each segment’s Adjusted EBITDA. The CODM is not regularly provided with and does not evaluate the segments using segment total assets and therefore, each segment’s total assets are not disclosed.
Segment profitability measures and significant expenses
The following table presents financial information for the Company’s reportable segments and significant expenses regularly provided to the CODM:

| Three Months Ended June 30, 2026 |  | Three Months Ended June 30, 2025
(In millions) | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Total |  | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Total
Revenue | $ | 467 |  |  | $ | 514 |  |  |  |  | $ | 421 |  |  | $ | 514 |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |
Cost of sales | 282 |  |  | 340 |  |  |  |  | 270 |  |  | 330 |  |  |
Research and development | 11 |  |  | 6 |  |  |  |  | 21 |  |  | 10 |  |  |
Other segment items (1) | 95 |  |  | 107 |  |  |  |  | 87 |  |  | 112 |  |  |
Add: |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization | 33 |  |  | 29 |  |  |  |  | 43 |  |  | 32 |  |  |
Segment Adjusted EBITDA | $ | 112 |  |  | $ | 90 |  |  | $ | 202 |  |  | $ | 86 |  |  | $ | 94 |  |  | $ | 180 |
Less: |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  |  |  | 13 |  |  |  |  |  |  | 29 |
Other income |  |  |  |  | (2) |  |  |  |  |  |  | (3) |
Restructuring related costs |  |  |  |  | 12 |  |  |  |  |  |  | 6 |
M&A related costs |  |  |  |  | 11 |  |  |  |  |  |  | 20 |
Impairment of intangible assets |  |  |  |  | 33 |  |  |  |  |  |  | — |
Loss on investment |  |  |  |  | — |  |  |  |  |  |  | 11 |
Depreciation and amortization |  |  |  |  | 66 |  |  |  |  |  |  | 82 |
Unallocated amounts: |  |  |  |  |  |  |  |  |  |  |
Corporate expense (2) |  |  |  |  | 34 |  |  |  |  |  |  | 24 |
Income before income taxes |  |  |  |  | $ | 35 |  |  |  |  |  |  | $ | 11 |
Capital expenditures |  |  |  |  | $ | 25 |  |  |  |  |  |  | $ | 19 |

25

| Six Months Ended June 30, 2026 |  | Six Months Ended June 30, 2025
(In millions) | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Total |  | Protein Solutions |  | Prepared Food and Beverage Solutions |  | Total
Revenue | $ | 927 |  |  | $ | 990 |  |  |  |  | $ | 799 |  |  | $ | 990 |  |  |
Less: |  |  |  |  |  |  |  |  |  |  |
Cost of sales | 571 |  |  | 658 |  |  |  |  | 517 |  |  | 644 |  |  |
Research and development | 22 |  |  | 13 |  |  |  |  | 41 |  |  | 20 |  |  |
Other segment items (1) | 189 |  |  | 219 |  |  |  |  | 163 |  |  | 213 |  |  |
Add: |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization | 67 |  |  | 60 |  |  |  |  | 71 |  |  | 59 |  |  |
Segment Adjusted EBITDA | $ | 212 |  |  | $ | 160 |  |  | $ | 372 |  |  | $ | 149 |  |  | $ | 172 |  |  | $ | 321 |
Less: |  |  |  |  |  |  |  |  |  |  |
Interest expense, net |  |  |  |  | 23 |  |  |  |  |  |  | 70 |
Other income |  |  |  |  | (4) |  |  |  |  |  |  | (5) |
Restructuring related costs |  |  |  |  | 10 |  |  |  |  |  |  | 17 |
M&A related costs |  |  |  |  | 19 |  |  |  |  |  |  | 94 |
Impairment of intangible assets |  |  |  |  | 33 |  |  |  |  |  |  | — |
Loss on investment |  |  |  |  | — |  |  |  |  |  |  | 11 |
Pension expense, other than service cost |  |  |  |  | — |  |  |  |  |  |  | 147 |
Depreciation and amortization |  |  |  |  | 134 |  |  |  |  |  |  | 143 |
Unallocated amounts: |  |  |  |  |  |  |  |  |  |  |
Corporate expense (2) |  |  |  |  | 62 |  |  |  |  |  |  | 52 |
Income before income taxes |  |  |  |  | $ | 95 |  |  |  |  |  |  | $ | (208) |
Capital expenditures |  |  |  |  | $ | 51 |  |  |  |  |  |  | $ | 39 |

(1) Other segment items for each reportable segment include operating expenses, which primarily consist of selling, general and administrative expenses and corporate and shared service expenses allocated to each segment based upon benefits received. Other segment items exclude the impact of restructuring, M&A and other one-time related costs as they do not reflect the ongoing operations of the underlying business.
(2) Corporate expense is primarily comprised of unallocated selling, general and administrative expenses and activity that does not meet the criteria of a reportable segment. Corporate expense excludes the impact of depreciation and amortization, restructuring, M&A and other one-time related and non-operating costs shown separately in the table above.
NOTE 15. RESTRUCTURING
Restructuring charges primarily consist of employee separation benefits under existing severance programs, foreign statutory termination benefits, certain one-time termination benefits, contract termination costs and other costs that are associated with restructuring actions. Certain restructuring charges are accrued prior to payments made in accordance with applicable guidance. For such charges, the amounts are determined based on estimates prepared at the time the restructuring actions were approved by management. Inventory write offs due to restructuring are reported in Cost of sales and all other restructuring charges are reported in Selling, general and administrative expense within the Condensed Consolidated Statements of Income.
In the first quarter of 2025, the Company implemented a restructuring plan (the “JBT Marel 2025 Integration restructuring plan”) aiming to achieve a portion of its synergy targets as a result of the Marel acquisition to optimize the overall cost structure for the combined Company on a global basis. The initiatives under this plan include streamlining operations and adjusting our general and administrative infrastructure to meet the strategic needs of the Company. The total estimated cost in connection w ith this plan is in the range of $55 million to $60 million. The Company expects to recognize the remaining costs by the end of 2026.
26

The following table summarizes the cumulative restructuring charges recognized in operating income under the Company's restructuring plans, including the JBT Marel 2025 Integration restructuring plan, from the date the plan was initiated through June 30, 2026.:

| Cumulative Amount |  | During the Quarter Ended |  | Cumulative Amount
(In millions) | Balance as of December 31, 2025 |  | March 31, 2026 |  | June 30, 2026 |  |  |  | Balance as of June 30, 2026
Severance and related expense, net of release | $ | 29 |  |  | $ | (2) |  |  | $ | 12 |  |  |  |  | $ | 39 |
Gain on sale of building | — |  |  | (1) |  |  | — |  |  |  |  | (1) |
Other | 2 |  |  | 1 |  |  | — |  |  |  |  | 3 |
Total restructuring charges, net | $ | 31 |  |  | $ | (2) |  |  | $ | 12 |  |  |  |  | $ | 41 |

Restructuring charges, net were $12 million and $6 million for the three months ended June 30, 2026 and 2025, respectively, primarily related to severance and related costs in both periods.
The following table details the restructuring liability balance for the JBT Marel 2025 Integration restructuring plan, recorded in Other current liabilities on the Condensed Consolidated Balance Sheets, for the six months ended June 30, 2026:

|  |  | Impact to Earnings |  |  |  |
(In millions) | Balance as of December 31, 2025 |  | Charged to Earnings |  | Releases(1) |  | Cash Payments |  | Balance as of June 30, 2026
Severance and related | $ | 16 |  |  | $ | 15 |  |  | $ | (5) |  |  | $ | (8) |  |  | $ | 18 |
Total | $ | 16 |  |  | $ | 15 |  |  | $ | (5) |  |  | $ | (8) |  |  | $ | 18 |

(1) Includes reductions of severance liabilities resulting from revisions to estimated severance payments and employee attrition.
27

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q, our Annual Report on Form 10-K and other materials filed or to be filed by us with the Securities and Exchange Commission, as well as information in oral statements or other written statements made or to be made by us, contain statements that are, or may be considered to be, forward-looking statements. All statements that are not historical facts, including statements about our beliefs or expectations, are forward-looking statements. You can identify these forward-looking statements by the use of forward-looking words such as “outlook,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “estimates,” “anticipates,” “foresees” or the negative version of those words or other comparable words and phrases. Any forward-looking statements contained in this Form 10-Q are based upon our historical performance and on current plans, estimates and expectations. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates or expectations contemplated by us will be achieved. These forward-looking statements include, among others, statements relating to our business and our results of operations, our strategic plans, our restructuring plans and expected cost savings from those plans and our liquidity. The factors that could cause our actual results to differ materially from expectations include, but are not limited to, the following factors:
•fluctuations in our financial results;
•termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation;
•catastrophic loss at any of our facilities and business continuity of our information systems;
•loss of key management and other personnel;
•our ability to remediate the material weaknesses relating to the Marel financial statements;
•deterioration of economic conditions, including impacts from supply chain delays and reduced material or component availability;
•unanticipated delays or acceleration in our sales cycles;
•inflationary pressures, including increases in energy, raw material, freight, and labor costs;
•changes in food consumption patterns;
•weather conditions and natural disasters;
•impacts of pandemic illnesses, food borne illnesses and diseases to various agricultural products;
•work stoppages;
•customer sourcing initiatives;
•competition and innovation in our industries;
•disruptions in the political, regulatory, economic and social conditions of the countries in which we conduct business;
•changes to tariffs, trade regulations, quotas, or duties;
•potential liability arising out of the installation or use of our systems;
•the impact of climate change and environmental protection initiatives;
•our ability to comply with U.S. and international laws governing our operations and industries;
•increases in tax liabilities;
•risks related to acquisitions, such as our ability to integrate the acquisitions we have consummated, including the integration of the legacy businesses of JBT and Marel;
•our ability to develop and introduce new or enhanced products and services and keep pace with technological developments;
•difficulty in developing, preserving and protecting our intellectual property or defending claims of infringement;
•cybersecurity risks such as network intrusion or ransomware schemes;
•our convertible note hedge and warrant transactions;
•the maintenance of two stock exchange listings;
•fluctuations in currency exchange rates and interest rates;
•our level of indebtedness;
•availability of and access to financial and other resources; and
•the factors described under the captions “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report on Form 10-K and in this and any future Quarterly Report on Form 10-Q.
28

If one or more of those or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, actual results may vary materially from what we projected. Consequently, actual events and results may vary significantly from those included in or contemplated or implied by our forward-looking statements. The forward-looking statements included in this Form 10-Q are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement made by us or on our behalf, whether as a result of new information, future developments, subsequent events or changes in circumstances or otherwise.
In this section, the Company utilizes non-GAAP measures to provide a more meaningful comparison of its ongoing operating results, consistent with how management evaluates performance. For further information regarding the Company's non-GAAP measures including reconciliations to the most directly comparable GAAP measures, see below "Reconciliation of Non-GAAP Measures."
The Company calculates amounts and percentages using rounded figures as presented in this section. In prior periods, amounts and percentages were calculated using unrounded values. As a result, certain amounts and percentages may differ slightly from previously presented information.
Executive Overview
JBT Marel Corporation is a leading global food and beverage technology solutions provider to high-value segments of the food and beverage industry. Fueled by our purpose, to transform the future of food, we help our customers maximize production output and performance through our diverse food application knowledge and integrated solutions offerings.
We specialize in designing, manufacturing, and servicing cutting-edge technology, systems, and software for a broad range of food and beverage end markets. We aim to create better outcomes for our diverse customers by optimizing food yield and efficiency, improving food safety and quality, and enhancing uptime and proactive maintenance, all while reducing waste and resource use across the global food supply chain.
In early 2026, we introduced our NextGen strategy that focuses on delivering comprehensive solutions to customers through our leading technology, life cycle support, and food application expertise. Our NextGen strategy includes four key pillars to deliver continued organic growth and margin expansion.
•Customer First Service Organization. Leveraging our global footprint and large installed base to strengthen customer partnerships through a more prescriptive service model. Our enhanced regional service capabilities and data driven approach allow us to improve on-time parts delivery, reduce unplanned downtime events, and optimize our customers’ operations.
•Integrated Value Proposition. Broadening and deepening our product leadership through targeted innovation. Our priorities include strengthening our full-line capabilities, allowing technology to seamlessly flow together as a cohesive system. We also are addressing customer pain points by creating differentiated solutions that increase yield and throughput while reducing waste, labor requirements, and energy usage.
•Capture Full Market Potential. Elevating commercial execution through our customer focused go-to-market strategy that drives cross-selling, accelerates growth in emerging markets, and enhances customer retention.
•Operational Distinctiveness. Harnessing our enterprise-wide relentless continuous improvement culture to reduce operational complexity, unlock efficiency gains, and enable margin improvement.
Our approach to Environmental, Social and Governance (ESG) initiatives is embedded in our overall company strategy and is advanced through five key pillars, related to:
•Our customers, to whom we offer diverse solutions, operational scale and application, service, and digital expertise focused on enabling customers to reach their sustainability goals;
•Our products and service solutions that offer efficient energy and water usage, extend product shelf life and equipment lifespans, contribute to food traceability and safety, and help minimize food loss;
29

•Our people and communities, for and with whom we are creating a values-driven workplace, ensuring all employees have the tools they need to succeed and experience a sense of belonging;
•Our operations, where we are integrating practices to reduce our greenhouse gas (GHG) emissions, curb energy use, minimize waste generation, and optimize water use; and
•Our supply partners, with whom we are engaging to better understand their environmental impact and identify collaborative opportunities to more effectively achieve common sustainability goals.
Strategic Acquisition of Marel hf.
On January 2, 2025, the Company closed the acquisition of Marel, a multi-national food processing company based in Gardabaer, Iceland that manufactures equipment and provides other services for food processing in the poultry, meat, fish, and pet food industries. The purpose of the Marel Transaction was to create a leading and diversified global food and beverage technology solutions provider by bringing together two renowned companies with long histories, complementary product portfolios, highly respected brands, and cutting-edge technology to enable global customers to more efficiently access industry leading technology worldwide. Refer to Note 2. Acquisitions of the Notes to the Consolidated Financial Statements for additional information on the Marel Transaction.
The disclosure s in this “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” of the Quarterly Report on Form 10-Q speak to the combined company subsequent to the Marel Transaction unless otherwise noted.
30

Business Conditions and Outlook
We achieved another strong quarter of inbound orders, demonstrating the value of our comprehensive solutions and cross-selling capabilities. Demand remained strong in the poultry end market, with meaningful investment in further processing technology. Additionally, we saw healthy demand in meat and beverage end markets with improved investment in warehouse automation after a few soft quarters. We delivered year-over-year growth in revenue and margins driven primarily by higher non-recurring revenue within the poultry end market and net tariff recoveries.
For the full year 2026, we continue to expect year-over-year growth in revenue, margins, and earnings per share, which are supported by our record backlog and operational improvement initiatives. At the same time, we are closely monitoring how rising inflation may impact the price-cost dynamics for both JBT Marel and our customers.
31

CONSOLIDATED RESULTS OF OPERATIONS
THREE MONTHS ENDED JUNE 30, 2026 AND 2025

| Three Months Ended June 30, |  | Favorable / (Unfavorable)
(In millions, except %) | 2026 |  | 2025 |  | Change |  | %
Revenue | 981 |  | 935 |  | 46 |  | 4.9%
Cost of sales | 622 |  | 600 |  | (22) |  | (3.7)%
Gross profit | 359 |  | 335 |  | 24 |  | 7.2%
Gross profit margin | 36.6% |  | 35.8% |  | 80 bps |  |
Selling, general and administrative expense | 313 |  | 287 |  | (26) |  | (9.1)%
Operating income | 46 |  | 48 |  | (2) |  | (4.2)%
Loss on investment | — |  | 11 |  | 11 |  | 100.0%
Interest expense, net | 13 |  | 29 |  | 16 |  | 55.2%
Other income | (2) |  | (3) |  | (1) |  | 33.3%
Income (loss) before income taxes | 35 |  | 11 |  | 24 |  | 218.2%
Income tax provision (benefit) | 7 |  | 8 |  | 1 |  | (12.5)%
Net income (loss) | $ | 28 |  | $ | 3 |  | $ | 25 |  | 833.3%
Adjusted EBITDA (1) | $ | 168 |  | $ | 156 |  | $ | 12 |  | 7.7%
Net income (loss) margin | 2.9% |  | 0.4% |  | 250 bps |  |
Adjusted EBITDA margin | 17.1% |  | 16.7% |  | 40 bps |  |

(1) Refer to the 'Reconciliation of Non-GAAP Measures' section below for additional information on Adjusted EBITDA.
Revenue
Total revenue for the three months ended June 30, 2026 increased $46 million, or 4.9%, compared to the same period in 2025. Organic revenue growth contributed $27 million, while favorable foreign currency translation contributed $19 million. The increase in organic revenue was primarily driven by higher volume in both recurring and non-recurring revenue.
Gross Profit and Gross Profit Margin
Gross profit margin increased 80 bps to 36.6% compared to 35.8% in 2025. The increase primarily reflected a favorable net tariff impact, including tariff recoveries recognized during the second quarter of 2026, higher sales volumes and improved leverage of fixed costs, partially offset by higher inflationary costs. Net tariff impact contributed 62 bps to the year-over-year increase in gross profit margin.
Selling, general and administrative expense
Selling, general and administrative expense increased $26 million and as a percentage of revenue increased 120 bps to 31.9% compared to 30.7% for the same period in the prior year. The increase was primarily driven by a one-time $33 million intangible asset impairment charge recorded during the second quarter of 2026, partially offset by lower acquisition-related depreciation and amortization expense compared to the prior-year period.
32

Interest expense, net
Interest expense, net, decreased by $16 million compared to the prior-year period, primarily due to benefits realized from the Company’s net investment hedges executed during the second and third quarters of 2025, as well as lower average debt balances during the period.
Income tax provision (benefit)
The effective tax rate on net income (loss) for the three months ended June 30, 2026 was 18.6%, compared to 68.1% for the same period in 2025. The 2026 tax rate reflected a favorable discrete tax benefit of $3 million resulting from the completion of the annual calculation of U.S. tax inclusions associated with prior-year foreign earnings. The 2025 tax rate was elevated due to lower pre-tax income and the impact of discrete tax expense totaling $3 million, primarily related to a non-deductible loss on investment and changes in the forecasted full-year effective tax rate.
Net income (loss) and Adjusted EBITDA
Net income for the three months ended June 30, 2026 was $28 million compared to $3 million for the same period in 2025, an increase of $25 million. The increase was primarily driven by higher revenue, lower acquisition-related depreciation and amortization expense, lower interest expense, and a favorable net tariff impact, partially offset by a $33 million intangible asset impairment charge recorded during the second quarter of 2026 and higher inflationary costs. Net income margin increased to 2.9% compared to 0.4% for the same period in 2025.
Adjusted EBITDA was $168 million for the three months ended June 30, 2026 compared to $156 million for the same period in 2025, an increase of $12 million. Adjusted EBITDA margin increased 40 bps to 17.1% compared to 16.7% in the prior-year period. The increase was primarily driven by a favorable net tariff impact, including tariff recoveries recognized during the second quarter of 2026, as well as higher sales volume and improved fixed-cost leverage. These benefits were partially offset by higher inflationary costs.
33

CONSOLIDATED RESULTS OF OPERATIONS
SIX MONTHS ENDED JUNE 30, 2026 AND 2025

| Six Months Ended June 30, |  | Favorable / (Unfavorable)
(In millions, except %) | 2026 |  | 2025 |  | Change |  | %
Revenue | 1,917 |  | 1,789 |  | 128 |  | 7.2%
Cost of sales | 1,229 |  | 1,162 |  | (67) |  | (5.8)%
Gross profit | 688 |  | 627 |  | 61 |  | 9.7%
Gross profit margin | 35.9% |  | 35.0% |  | 90 bps |  |
Selling, general and administrative expense | 574 |  | 612 |  | 38 |  | 6.2%
Operating income | 114 |  | 15 |  | 99 |  | 660.0%
Pension expense, other than service cost | — |  | 147 |  | 147 |  | 100.0%
Loss on investment | — |  | 11 |  | 11 |  | 100.0%
Interest expense, net | 23 |  | 70 |  | 47 |  | 67.1%
Other income | (4) |  | (5) |  | (1) |  | 20.0%
Income (loss) before income taxes | 95 |  | (208) |  | 303 |  | (145.7)%
Income tax provision (benefit) | 22 |  | (38) |  | (60) |  | 157.9%
Net income (loss) | $ | 73 |  | $ | (170) |  | $ | 243 |  | (142.9)%
Adjusted EBITDA (1) | $ | 310 |  | $ | 268 |  | $ | 42 |  | 15.7%
Net income (loss) margin | 3.8% |  | (9.5)% |  | 1330 bps |  |
Adjusted EBITDA margin | 16.2% |  | 15.0% |  | 120 bps |  |

(1) Refer to the 'Reconciliation of Non-GAAP Measures' section below for additional information on Adjusted EBITDA.
Revenue
Total revenue for the six months ended June 30, 2026 increased $128 million or 7.2%, compared to the same period in 2025. Organic revenue contributed $57 million, while favorable foreign currency translation contributed $71 million. The increase in organic revenue was primarily driven by higher volume in both recurring and non-recurring revenue.
Gross Profit and Gross Profit Margin
Gross profit margin increased 90 bps to 35.9% compared to 35.0% in 2025. The increase primarily reflected higher sales volume and improved fixed-cost leverage. These favorable factors were partially offset by higher inflationary costs and net tariff-related impact, which represented a 42 bps year-over-year headwind to gross profit margin, inclusive of tariff recoveries recognized during the second quarter of 2026.
Selling, general and administrative expense
Selling, general and administrative expense decreased $38 million compared to the same period in the prior year. Selling, general and administrative expense as a percentage of revenue decreased 430 bps to 29.9% compared to 34.2% in the same period last year. The decrease was primarily driven by lower acquisition-related depreciation and amortization expense and lower transaction and integration costs compared to the prior-year period.
34

Pension expense, other than service cost
Pension expense, other than service cost decreased $147 million compared to the same period in the prior year. This decrease was attributable to a one-time $147 million settlement charge recognized in the first quarter of 2025 upon the termination of the U.S. qualified defined benefit pension plan.
Interest expense, net
Interest expense, net decreased $47 million compared with the prior-year period, primarily due to the release of capitalized debt issuance costs associated with the termination of the Company’s bridge credit agreement in the first quarter of 2025, as well as benefits from the Company's net investment hedges executed during the second and third quarters of 2025.
Income tax provision (benefit)
The effective tax rate on net income for the six months ended June 30, 2026 was 23.0%, compared with 18.4% on a pretax loss for the same period in 2025. In 2026, the tax rate was favorably impacted by discrete tax benefits of $2 million, primarily related to stock-based compensation and the completion of the annual calculations of U.S. tax inclusions associated with prior-year foreign earnings. These benefits were partially offset by tax expense resulting from a change in the Company’s indefinite reinvestment assertion related to foreign earnings. In 2025, the tax benefit on the pretax loss was reduced by discrete tax expense totaling $5 million, primarily driven by non-deductible acquisition costs and a non-deductible loss on investment.
Net income (loss) and Adjusted EBITDA
Net income for the six months ended June 30, 2026 was $73 million compared to a net loss of $170 million for the same period in 2025, representing an increase of $243 million. The improvement was primarily driven by lower transaction, integration, and pension-related costs compared to the prior-year period, as well as higher sales volume and improved leverage of fixed costs. As a result, net income (loss) margin increased to 3.8%, compared to (9.5)% for the same period in 2025.
Adjusted EBITDA was $310 million for the six months ended June 30, 2026, compared to $268 million for the same period in 2025, representing an increase of $42 million. Adjusted EBITDA margin increased 120 bps to 16.2% compared to 15.0% for the same period in 2025. The increases in Adjusted EBITDA and Adjusted EBITDA margin were primarily driven by higher sales volume and improved leverage of fixed costs compared to the prior-year period, partially offset by higher inflationary costs and net tariff costs, inclusive of tariff recoveries recognized during the second quarter of 2026, which remained a headwind during the period.
35

OPERATING RESULTS OF BUSINESS SEGMENTS
THREE MONTHS ENDED JUNE 30, 2026 AND 2025

| Three Months Ended June 30, |  | Favorable / (Unfavorable)
(In millions, except %) | 2026 |  | 2025 |  | Change |  | %
Revenue |  |  |  |  |  |  |
Protein Solutions | $ | 467 |  |  | $ | 421 |  |  | $ | 46 |  |  | 10.9 | %
Prepared Food and Beverage Solutions | 514 |  |  | 514 |  |  | — |  |  | — | %
Total revenue | $ | 981 |  |  | $ | 935 |  |  | $ | 46 |  |  | 4.9 | %
Segment Adjusted EBITDA (1) |  |  |  |  |  |  |
Protein Solutions | $ | 112 |  |  | $ | 86 |  |  | $ | 26 |  |  | 30.2 | %
Prepared Food and Beverage Solutions | 90 |  |  | 94 |  |  | (4) |  |  | (4.3) | %
Segment Adjusted EBITDA margin |  |  |  |  |  |  |
Protein Solutions | 24.0 | % |  | 20.5 | % |  | 350 bps |  |
Prepared Food and Beverage Solutions | 17.5 | % |  | 18.2 | % |  | -70 bps |  |

(1) Refer to Note 14. Business Segment Information of the Notes to Condensed Consolidated Financial Statements for additional information on segment Adjusted EBITDA.
Protein Solutions
Protein Solutions segment revenue increased by $46 million or 10.9% during the three months ended June 30, 2026, compared to the same period in 2025, of which favorable currency translation contributed $11 million. Organic revenue growth was primarily driven by higher recurring revenue and a recovery in non-recurring project activity within poultry end markets compared to the prior‑year period.
Protein Solutions segment Adjusted EBITDA was $112 million or 24.0% of segment revenue, for the three months ended June 30, 2026, compared to $86 million, or 20.5% of segment revenue, for the same period in 2025. The increase of $26 million, or 30.2%, was primarily driven by higher gross margin resulting from increased volume, synergy realization and a favorable net tariff impact, partially offset by higher inflationary costs. Adjusted EBITDA margin increased 350 bps from the prior-year period.
Prepared Food and Beverage Solutions
Prepared Food and Beverage Solutions segment revenue was flat for the three months ended June 30, 2026, compared to the same period in 2025, including an $8 million benefit from favorable foreign currency translation. Organic revenue declined during the period, primarily driven by lower equipment volumes across certain end markets within the segment.
Prepared Food and Beverage Solutions segment Adjusted EBITDA was $90 million, or 17.5%, of segment revenue, for the three months ended June 30, 2026, compared to $94 million, or 18.2% of segment revenue, for the same period in 2025. The decrease of $4 million, or 4.3%, was primarily driven by productivity inefficiencies associated with efforts to optimize the segment’s manufacturing footprint and supply chain operations, as well as higher inflationary costs. These factors were partially offset by a favorable net tariff impact. Adjusted EBITDA margin decreased 70 bps from the prior-year period.
36

OPERATING RESULTS OF BUSINESS SEGMENTS
SIX MONTHS ENDED JUNE 30, 2026 AND 2025

| Six Months Ended June 30, |  | Favorable / (Unfavorable)
(In millions, except %) | 2026 |  | 2025 |  | Change |  | %
Revenue |  |  |  |  |  |  |
Protein Solutions | $ | 927 |  |  | $ | 799 |  |  | $ | 128 |  |  | 16.0 | %
Prepared Food and Beverage Solutions | 990 |  |  | 990 |  |  | — |  |  | — | %
Total revenue | $ | 1,917 |  |  | $ | 1,789 |  |  | $ | 128 |  |  | 7.2 | %
Segment Adjusted EBITDA (1) |  |  |  |  |  |  |
Protein Solutions | $ | 212 |  |  | $ | 149 |  |  | $ | 63 |  |  | 42.3 | %
Prepared Food and Beverage Solutions | 160 |  |  | 172 |  |  | (12) |  |  | (7.0) | %
Segment Adjusted EBITDA margin |  |  |  |  |  |  |
Protein Solutions | 22.9 | % |  | 18.6 | % |  | 430 bps |  |
Prepared Food and Beverage Solutions | 16.2 | % |  | 17.4 | % |  | -120 bps |  |

(1) Refer to Note 14. Business Segment Information of the Notes to Condensed Consolidated Financial Statements for additional information on segment Adjusted EBITDA.
Protein Solutions
Protein Solutions segment revenue increased by $128 million, or 16.0%, during the six months ended June 30, 2026, compared to the same period in 2025, including a $42 million benefit from favorable currency translation. Organic revenue growth was primarily driven by higher recurring revenue and a recovery in non-recurring project activity within poultry end markets compared to the prior-year period.
Protein Solutions segment Adjusted EBITDA was $212 million or 22.9% of segment revenue, for the six months ended June 30, 2026, compared to $149 million, or 18.6% of segment revenue, for the same period in 2025. The increase of $63 million, or 42.3%, was primarily driven by higher gross margins resulting from increased volume and synergy realization. Adjusted EBITDA margin increased 430 bps compared to the prior-year period.
Prepared Food and Beverage Solutions
Prepared Food and Beverage Solutions segment revenue was flat for the six months ended June 30, 2026 compared to the same period in 2025, including a $29 million benefit from favorable foreign currency translation. Organic revenue declined during the period, primarily driven by lower equipment volumes across certain end markets within the segment.
Prepared Food and Beverage Solutions segment Adjusted EBITDA was $160 million, or 16.2% of segment revenue, for the six months ended June 30, 2026, compared to $172 million, or 17.4% of segment revenue, for the same period in 2025. The decrease of $12 million, or 7.0%, was primarily driven by lower backlog-to-revenue conversion and reduced operational efficiencies within the segment's manufacturing and supply chain operations during the period. Adjusted EBITDA margin decreased 120 bps compared to the prior-year period.
37

Reconciliation of Non-GAAP Measures
We present non-GAAP financial measures in this quarterly report on Form 10-Q. These non-GAAP financial measures adjust for certain amounts that are otherwise included or excluded from a measure calculated under U.S. GAAP. By adjusting for these items, we believe we provide greater transparency into our operating results and trends, and a more meaningful comparison of our ongoing operating results, consistent with how management evaluates performance. Management uses these non-GAAP financial measures in financial and operational evaluation, planning and forecasting. We also believe that these non-GAAP measures are useful to investors as a way to evaluate and compare our operating performance against peers in the Company's industry. The adjustments generally fall within the following categories: restructuring related costs, M&A related costs, pension-related costs, and other major items affecting comparability of our ongoing operating results.
The non-GAAP financial measures presented in this report may differ from similarly-titled measures used by other companies. The non-GAAP financial measures are not intended to be used as a substitute for, nor should they be considered in isolation of, financial measures prepared in accordance with U.S. GAAP.
Additional details for each Non-GAAP financial measure follow:
•Adjusted EBITDA and Adjusted EBITDA margin: We define Adjusted EBITDA as earnings before income taxes, interest expense (income), net, other financing income, pension expense other than service cost, restructuring costs, M&A related costs, including acquisition and integration-related expenses, one-time impairment charges, and depreciation and amortization, including acquisition-related depreciation and amortization. We define Adjusted EBITDA margin as Adjusted EBITDA divided by revenue.
•Adjusted income and adjusted diluted earnings per share: We adjust earnings for restructuring costs, M&A related costs, including acquisition and integration-related expenses, one-time impairment charges, inventory step-up amortization from business combinations; acquisition-related amortization and depreciation, acquisition financing costs, non-cash service pension costs and the related tax effects of these adjustments.
•Free cash flow: We define free cash flow as cash provided by operating activities, less capital expenditures, plus proceeds from sale of fixed assets and pension contributions.
The tables below reconcile each non-GAAP financial measure to the most comparable GAAP financial measure.
38

The following table presents a reconciliation of the Company's reported income (loss) to Adjusted EBITDA.

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions) | 2026 |  | 2025 |  | 2026 |  | 2025
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Income tax provision (benefit) | 7 |  |  | 8 |  |  | 22 |  |  | (38) |
Interest expense, net | 13 |  |  | 29 |  |  | 23 |  |  | 70 |
Other financing income (1) | (2) |  |  | (3) |  |  | (4) |  |  | (5) |
Restructuring and related costs, net (2) | 12 |  |  | 6 |  |  | 10 |  |  | 17 |
M&A related costs (3) | 11 |  |  | 20 |  |  | 19 |  |  | 94 |
Impairment of intangible assets (4) | 33 |  |  | — |  |  | 33 |  |  | — |
Loss on investment | — |  |  | 11 |  |  | — |  |  | 11 |
Pension expense, other than service cost (5) | — |  |  | — |  |  | — |  |  | 147 |
Depreciation and amortization expense (6) | 66 |  |  | 82 |  |  | 134 |  |  | 143 |
Adjusted EBITDA | $ | 168 |  |  | $ | 156 |  |  | $ | 310 |  |  | $ | 268 |

(1) Other financing income represents transaction gains from fair value hedges on our foreign currency denominated debt, and are considered non-operating as they relate to our cost of borrowing debt.
(2) Costs associated with restructuring actions, primarily consisting of severance and related employee costs.
(3) Advisory, strategy, integration, and other costs associated with completed M&A transactions. These costs are attributable to the integration of acquired businesses and are not considered indicative of ongoing operating performance.
(4) Non-cash impairment charge related to acquired intangible assets recorded in the second quarter of 2026.
(5) Non service-related pension expense, which consists of non-cash interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlement charges.
(6) Depreciation and amortization, including acquisition related amortization and depreciation expense, is excluded to determine Adjusted EBITDA.
39

The table below provides a reconciliation of income (loss) as reported to adjusted income and adjusted diluted earnings per share.

| Three Months Ended June 30, |  | Six Months Ended June 30,
(In millions, except per share data) | 2026 |  | 2025 |  | 2026 |  | 2025
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Non-GAAP adjustments |  |  |  |  |  |  |
Restructuring and related costs, net (1) | 12 |  |  | 6 |  |  | 10 |  |  | 17 |
M&A related costs (2) | 11 |  |  | 20 |  |  | 19 |  |  | 94 |
Impairment of intangible assets (3) | 33 |  |  | — |  |  | 33 |  |  | — |
Acquisition related depreciation and amortization (4) | 42 |  |  | 58 |  |  | 87 |  |  | 100 |
Loss on investment | — |  |  | 11 |  |  | — |  |  | 11 |
Amortization of bridge financing debt issuance cost | — |  |  | — |  |  | — |  |  | 12 |
Impact from tax provision on Non-GAAP adjustments (5) | (24) |  |  | (20) |  |  | (37) |  |  | (51) |
Recognition of non-cash pension plan related settlement costs | — |  |  | — |  |  | — |  |  | 147 |
Impact on tax provision from non-cash pension plan related settlement costs | — |  |  | — |  |  | — |  |  | (37) |
Discrete tax adjustment from M&A activity | — |  |  | — |  |  | — |  |  | 5 |
Adjusted income | $ | 102 |  |  | $ | 78 |  |  | $ | 185 |  |  | $ | 128 |
Net income (loss) | $ | 28 |  |  | $ | 3 |  |  | $ | 73 |  |  | $ | (170) |
Total shares and dilutive securities | 52.2 |  |  | 52.2 |  |  | 52.3 |  |  | 51.9 |
Diluted earnings (loss) per share | $ | 0.54 |  |  | $ | 0.07 |  |  | $ | 1.40 |  |  | $ | (3.27) |
Adjusted income | $ | 102 |  |  | $ | 78 |  |  | $ | 185 |  |  | $ | 128 |
Total shares and dilutive securities | 52.2 |  |  | 52.2 |  |  | 52.3 |  |  | 52.0 |
Adjusted diluted earnings per share | $ | 1.95 |  |  | $ | 1.49 |  |  | $ | 3.54 |  |  | $ | 2.46 |

(1) Costs associated with restructuring actions, primarily consisting of severance and related employee costs.
(2) Advisory, strategy, integration, and other costs associated with completed M&A transactions. These costs are attributable to the integration of acquired businesses and are not considered indicative of ongoing operating performance.
(3) Non-cash impairment charge related to acquired intangible assets recorded in the second quarter of 2026.
(4) Amortization and depreciation resulting from the fair value adjustments recorded in connection with acquisitions.
(5) Impact on tax provision was calculated using the enacted rate for the relevant jurisdiction for each period shown.
The table below provides a reconciliation of cash provided by operating activities to free cash flow:

| Six Months Ended June 30,
(in millions) | 2026 |  | 2025
Cash provided by operating activities | $ | 221 |  |  | $ | 137 |
Less: capital expenditures | 51 |  |  | 39 |
Plus: proceeds from sale of fixed assets | 9 |  |  | 5 |
Plus: pension contributions | — |  |  | 3 |
Free cash flow (FCF) | $ | 179 |  |  | $ | 106 |

40

Restructuring
In the first quarter of 2025, the Company implemented a restructuring plan (the “JBT Marel 2025 Integration Restructuring Plan”) to achieve a portion of its synergy targets as a result of the Marel acquisition to optimize the overall cost structure for the combined Company on a global basis. The initiatives under this plan include streamlining operations and adjusting our general and administrative infrastructure to meet the strategic needs of the Company. The total estimated cost in connection with this plan is in the range of $55 million to $60 million. The Company recognized cumulativ e restructuring charges of $41 million through June 30, 2026 and expects to recognize the remaining costs by the end of 2026.
The following table details the cumulative amount of annualized savings and incremental savings for the JBT Marel 2025 Integration restructuring plan:

| Cumulative Amount |  | Incremental Amount |  | Cumulative Amount
(In millions) | As of December 31, 2025 |  | During the quarter ended March 31, 2026 |  | During the quarter ended June 30, 2026 |  |  |  | As of June 30, 2026
Cost of sales | $ | 4 |  |  | $ | 2 |  |  | $ | 2 |  |  |  |  | $ | 8 |
Selling, general and administrative | 23 |  |  | 9 |  |  | 3 |  |  |  |  | 35 |
Total restructuring savings | $ | 27 |  |  | $ | 11 |  |  | $ | 5 |  |  |  |  | $ | 43 |

Cumulative cost savings for the JBT Marel 2025 Integration restructuring plan are expected to be between $65 million and $75 million.
For additional financial information about restructuring, refer to Note 15. Restructuring of the Notes to the Condensed Consolidated Financial Statements.
Liquidity and Capital Resources
Overview of Sources and Uses of Cash
Our primary sources of liquidity include our cash flows generated from operations and availability under our revolving credit facility.
For the six months ended June 30, 2026, we had total operating cash flows of $221 million. Our liquidity as of June 30, 2026, or cash plus borrowing ability under our existing revolving credit facility, was $1.4 billion.
Based on our current capital allocation objectives, we anticipate capital expenditures to be between $105 million and $120 million duri ng 2026. Our level of capital expenditures varies from time to time as a result of actual and anticipated business conditions. Duri ng 2026, we also expect to incur integration costs and other synergy-related costs in the range of $45 million to $55 million related to the acquisition of Marel in the first quarter of 2025.
Additionally, the cash flows generated by our operations are expected to be sufficient to satisfy our principal cash requirements that include our working capital needs, new product development, restructuring expenses, capital expenditures, income taxes, debt interest and repayments, dividends, share repurchases and other financing arrangements.
As of June 30, 2026, we had $93 million of unrestricted cash and cash equivalents, $84 million of which was held by our foreign subsidiaries. Although certain funds are considered permanently invested in our foreign subsidiaries, we are not presently aware of any restriction on the repatriation of these funds. We maintain significant operations outside of the U.S., and many of our uses of cash for working capital and capital expenditures arise in these foreign jurisdictions. If these funds were needed to fund our operations or satisfy obligations in the U.S., they could be repatriated and their repatriation into the U.S. could cause us to incur additional U.S. income tax and foreign withholding taxes. The foreign withholding taxes on these repatriations to the U.S. would potentially be partially offset by U.S. foreign tax credits.
41

As noted above, certain funds held outside of the U.S. are considered permanently invested in our non-U.S. subsidiaries. At times, these foreign subsidiaries have cash balances that exceed their immediate working capital or other cash needs. In these circumstances, the foreign subsidiaries may loan funds to the U.S. parent company on a temporary basis; the U.S. parent company has in the past and may in the future use the proceeds of these temporary intercompany loans to reduce outstanding borrowings under our committed credit facilities. By using available non-U.S. cash to repay our debt on a short-term basis, we can optimize our leverage ratio, which has the effect of lowering our interest costs.
Cash Flows
Cash flows for the six months ended June 30, 2026 and 2025 were as follows:

| Six Months Ended June 30,
(In millions) | 2026 |  | 2025
Cash provided by operating activities | $ | 221 |  |  | $ | 137 |
Cash required by investing activities | (42) |  |  | (1,780) |
Cash (required) provided by financing activities | (254) |  |  | 543 |
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | 2 |
Net (decrease) increase in cash | $ | (75) |  |  | $ | (1,098) |

Cash provided by operating activities during the six months ended June 30, 2026 was $221 million, representing a $84 million increase compared to the same period in 2025. The increase was primarily driven by improved operating performance and higher customer advance resulting from increased demand. These favorable impacts were partially offset by increased trade receivables and contract assets resulting from the timing of customer billings and collections.
Cash required by investing activities was $42 million during the six months ended June 30, 2026, compared to cash required of $1,780 million during the same period in 2025. The decrease in cash outflows during the period reflects the absence of acquisition-related payments in 2026, as the acquisition of Marel was completed in the first quarter of 2025.
Cash required by financing activities was $254 million during the six months ended June 30, 2026, compared to cash provided of $543 million during the same period in 2025. The decrease was primarily due to the absence of financing proceeds obtained in connection with the Marel acquisition in 2025, partially offset by repayments of the 2026 Notes in the second quarter of 2026.
Financing Arrangements
On January 2, 2025, we executed takeout financing consisting of an amended and restated 5-year, $1.8 billion revolving credit facility and a 7-year, $900 million senior secured Term Loan B.
As of June 30, 2026, we had $1.4 billion of availability under the revolving credit facility.
Our Second A&R Credit Agreement includes restrictive covenants that, if not met, could lead to a renegotiation of our credit lines, a requirement to repay our borrowings and/or a significant increase in our cost of financing. Restrictive covenants include a minimum interest coverage ratio, a maximum leverage ratio, as well as certain events of default. As of June 30, 2026, we were in compliance with all covenants in the Second A&R Credit Agreement. We expect to remain in compliance with all covenants.
Concurrently with the issuances of the 2030 Notes, we entered into convertible note hedge transactions and warrant transactions.
In the second quarter of 2026, the Company’s 2026 Notes, which were issued in the second quarter of 2021, matured. The Company satisfied the outstanding principal amount of $403 million through cash repayment at maturity in the second quarter of 2026.
The Company has outstanding warrants related to its 2026 Notes, which were repaid in full during the second quarter of 2026. The warrants expire in August 2026 and are not expected to have a material impact on the Company's financial position, results of operations, or cash flows.
42

For additional information about our borrowings, refer to Note 6. Debt of the Notes to the Condensed Consolidated Financial Statements.
As of June 30, 2026, a portion of our total gross outstanding debt of $1,705 million effectively remained fixed rate debt, with the 2030 Notes subject to a fixed rate of 0.375%. Our revolving credit facility and Term Loan B are subject to floating, or market rates, in addition to a premium charged for their respective credit spreads. Approximately $1,130 million or 66% of the total debt balance as of June 30, 2026 was variable rate debt and subject to floating rates.
On January 3, 2025, we entered into five cross-currency swaps expiring in January 2032 related to the portion of the U.S. dollar denominated Term Loan B debt drawn down by JBT Marel's European entity. These cross currency swap agreements have a combined notional amount of $691 million and synthetically swapped an average SOFR interest rate of 3.69% with an average EURIBOR rate of 1.93% for the six months ended June 30, 2026, to hedge the impact of variability in exchange rates on the U.S. dollar denominated debt and related interest payments, excluding credit spread, by our euro-functional entity.
CRITICAL ACCOUNTING ESTIMATES
There were no material changes in our judgments and assumptions associated with the development of our critical accounting estimates during the period ended June 30, 2026. Refer to our Annual Report on Form 10-K for the year ended December 31, 2025 for a discussion of our critical accounting estimates.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes in reported market risks from the information reported in our Annual Report on Form 10-K for the year ended December 31, 2025.
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, management of the Company carried out an evaluation, with the participation of the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).
As previously disclosed in the Company’s Annual Report on Form 10-K for the year ended 2025, prior to the acquisition of Marel hf. (“Marel”), Marel management identified material weaknesses in its internal control over financial reporting, which are described below. The acquired business was previously excluded from the Company’s internal control over financial reporting assessment under SEC staff guidance but is included in the Company’s assessment for the current fiscal year.
Conclusion on Effectiveness
In accordance with SEC guidance, the Company recognizes the substantial overlap between a company’s disclosure controls and procedures and its internal control over financial reporting. Due to the material weaknesses in internal control over financial reporting described below, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were not effective as of June 30, 2026. Notwithstanding this conclusion, in the opinion of management, including the Company’s Chief Executive Officer and Chief Financial Officer, the unaudited condensed consolidated financial statements in this Quarterly Report on Form 10-Q fairly present, in all material respects, our financial condition as reported in conformity with U.S. GAAP.
Previously Identified Material Weaknesses in Internal Control Over Financial Reporting
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
Prior to the acquisition, the management of Marel, which was not previously required to comply with the internal controls requirement of the Sarbanes-Oxley Act or U.S. GAAP, identified the following material weaknesses in its internal control over financial reporting, which remained unremediated as of June 30, 2026:
43

•Information Technology: The Company’s acquired entity, Marel, did not design and maintain effective information technology general controls for information systems that are relevant to financial reporting. Specifically, the acquired entity did not design and maintain: (i) program change management controls to ensure that information technology program and data changes are identified, tested, authorized, and implemented appropriately; (ii) user access controls to ensure appropriate segregation of duties and to adequately restrict user and privileged access to appropriate personnel; (iii) computer operations controls to ensure that processing and transfer of data, and data backups and recovery are monitored; and (iv) program development controls to ensure that new software development is tested, authorized, and implemented appropriately.
These IT deficiencies did not result in a material misstatement to the consolidated financial statements, however, the deficiencies, when aggregated, could impact maintaining effective segregation of duties, as well as the effectiveness of IT-dependent controls (such as automated controls that address the risk of material misstatement to one or more assertions, along with the IT controls and underlying data that support the effectiveness of system-generated data and reports) that could result in misstatements potentially impacting all financial statement accounts and disclosures that would not be prevented or detected.
•Journal entries: The Company’s acquired entity, Marel, did not design and maintain effective controls over the recording and review of journal entries for validity, accuracy, and completeness. Specifically, certain key accounting personnel have the ability to prepare and post journal entries without an appropriately designed independent review. This material weakness did not result in a material misstatement to the consolidated financial statements.
While the above material weaknesses have not resulted in a material misstatement to the consolidated financial statements, such material weaknesses resulted in misstatements that were not material to our consolidated financial statements as of and for the three months ended March 31, 2025. The above material weaknesses could result in misstatements of Marel’s financial statement accounts or disclosures to the annual or interim consolidated financial statements that would not be prevented or detected.
Remediation Plan and Progress
The Company is committed to remediating the material weaknesses and has taken, or is in the process of taking, the following remediation measures:
•Applied a risk‑based approach to prioritize the design of controls related to information technology and journal entry processing controls.
•Configuration of controls related to user access and change management within information technology environments impacting financial reporting, with ongoing evaluation of control design, implementation, and operating effectiveness.
•Configured system‑based, role‑based access controls over journal entry processing, with ongoing evaluation of control design, implementation, and operating effectiveness.
•Continuing to perform manual control activities designed to mitigate risks associated with the identified control deficiencies while remediation efforts are ongoing.
•Continued engagement of external advisors to support remediation efforts, including project management and guidance on control design and documentation.
•Conducting targeted training efforts and hired personnel with relevant internal control experience to support remediation and ongoing control performance.
As management continues to evaluate the Company’s internal control over financial reporting, the Company may take additional measures to address control deficiencies or may modify certain remediation measures described above.
Management has substantially completed the design of its remediated controls. The material weaknesses will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls operate effectively.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting identified in the evaluation for the quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.
44

PART II — OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we may be subject to legal proceedings and claims arising in the ordinary course of our business. We are not currently a party to or aware of any proceedings that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.
ITEM 1A. RISK FACTORS
There have been no material changes in reported risk factors from the information reported in Item 1A. “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table includes information about the Company’s stock repurchases during the three months ended June 30, 2026:

(Dollars in millions, except per share amounts) |  |  |  |  |  |  |
Period | Total Number of Shares Purchased |  | Average Price Paid per Share |  | Total Number of Shares Purchased as part of Publicly Announced Program |  | Approximate Dollar Value of Shares that may yet be Purchased under the Program (1)
April 1, 2026 through April 30, 2026 | — |  |  | $ | — |  |  | — |  |  | $ | — |
May 1, 2026 through May 31, 2026 | 150,000 |  |  | 129.34 |  |  | 150,000 |  |  | 181 |
June 1, 2026 through June 30, 2026 | 49,800 |  |  | 128.45 |  |  | 49,800 |  |  | 174 |
| 199,800 |  |  |  |  | 199,800 |  |  |

(1) On May 14, 2026, the Company’s Board of Directors authorized a share repurchase program for the purchase of up to $200 million of the Company’s common stock, effective from May 18, 2026, through May 31, 2029 (the “Share Repurchase Program”). Repurchases under the Share Repurchase Program may be made from time to time in the open market, through privately negotiated transactions, or by other means, in accordance with applicable securities laws. The manner, timing, price and volume of repurchases will be determined by the Company at its discretion, subject to market conditions, relevant securities laws and other factors.
The Share Repurchase Program does not obligate the Company to repurchase any particular amount of common stock and may be suspended, modified, or discontinued at any time without prior notice.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
Rule 10b5-1 Trading Plans
During the three months ended June 30, 2026, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement,” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
45

ITEM 6. EXHIBITS
EXHIBIT INDEX

Number in Exhibit Table |  | Description
31.1* |  | Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) /15d-14(a).
31.2* |  | Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) /15d-14(a).
32.1* |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2* |  | Certification of Chief Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS* |  | XBRL Instance Document
101.SCH* |  | XBRL Taxonomy Extension Schema Document
101.CAL* |  | XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF* |  | XBRL Taxonomy Extension Definition Linkbase Document
101.LAB* |  | XBRL Taxonomy Extension Label Linkbase Document
101.PRE* |  | XBRL Taxonomy Extension Presentation Linkbase Document
104* |  | Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).
* |  | Filed herewith.

46

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

JBT Marel Corporation |
(Registrant) |
/s/ Andrew Moller |
Andrew Moller |
Senior Vice President and Chief Accounting Officer |
(Authorized Officer and Principal Accounting Officer) |

Date: August 5, 2026
47